Invited Presentations Given Between July 1, 2001 – June 30 ...
Invited Presentations July 1, 2001 – June 30, 2004
Dr. Michelle Alfa
“Infection Control Issues Related to Reprocessing Medical Devices”. Presented at the FUDESA Conference. Buenos Aires, Argentina. October 15 – 16, 2004.
“Infection Control in the GI-Unit; Value of Routine Bioburden Testing for Flexible Endoscopes”. Presented at the Canadian Society of Gastroenterology Nurses and Associates 20th Annual Conference. Calgary, Alberta. Sept. 22 – 26, 2004.
“Battling the Bugs with Antiseptics and Disinfectants”. Presented at the Infection Prevention and Control Conference – CHICA. Winnipeg, Manitoba. June 11, 2004.
“Reprocessing of Lummened Instruments” – Meet the Expert; Flexible Endoscopes”. Presented at the 31st Annual Education Conference and International Meeting. Phoenix, Arizona. June 6 – 10, 2004.
“Endoscopy Reprocessing, Problem Areas and Prevention”. Presented at the Reprocessing of Medical Devices: Multi-use and Single-Use Conference – Ontario Hospital Association. Toronto, Ontario. April 1 – 2, 2004.
“Reprocessing of flexible endoscopes not designated to be sterile”. Presented at the International Congress of the German Society for Hospital Hygiene. Berlin, Germany. April 4 – 7, 2004.
“Endoscope Reprocessing Problem Areas & Prevention Strategies”. Presented at the Webber Training and Teleconference. February 12, 2004.
“Cleaning of Reusable Medical Devices”. Presented at the Webber Training and Teleconference. October 9, 2003.
“Early Onset Sepsis in Neonates”. Presented at the Manitoba Congress (MSMLT). Brandon, Manitoba. October 7, 2003.
“Infection Control and GI Endoscopy: The New Scoop on Some Old Poop!”. Presented at the Canadian Society of Gastroenterology Nurses and Associates (CSGNA) Annual Conference. Toronto, Ontario. September 18 – 20, 2003.
“Challenges Associated with Adequate Cleaning of Reusable Narrow-Lumen Medical Devices”. Presented at the Food and Drug Administration. Washington, D.C. May 14, 2003.
“Reprocessing of Flexible Endoscopes: What’s New up the Wazoo”, and “Cleaning Issues for Narrow Lumen Laparascopic Devices”. Presented at the International Association of Healthcare Central Service Materiel Management (IAHCSMM) Meeting. Branson, Michigan. April 27-30, 2003.
“Endoscope Reprocessing”. Presented at the SciCan Inc. Continuing Education Evening, Halifax, NS. February 18, 2003.
“Safe Reprocessing of Single-Use Medical Devices: Is there evidence to direct best practice?” Presented at the Ontario Hospital Association Conference on Reuse of Single-Use Medical Devices. Toronto, Ontario. February 1, 2003
“Reprocessing of Narrow Lumen Medical Devices”. Presented at the Webber Training and Teleconference. December 5, 2002.
“Effects of organic and inorganic material or the efficiency of sterilization processes”. Presented at the 2nd Pan-American Congress on Sterilization. Lima, Peru. November 13 - 15, 2002.
“Reprocessing of Narrow Lumen Medical Devices”, and “Cardiac Catheter; Reprocessing issues”. Presented at the Sterilization and Disinfection Symposium. Sao Paul, Brazil. July 25 - 27, 2002.
“Medical Device Reprocessing Issues Related to CJD”. Presented at the Annual APIC meeting, Michigan Chapter. Southfield, Michigan. July 30, 2002.
“Infection Control Issues Related to Device Reprocessing”. Presented at the Golden Gate Central Processing Association Seminar 2002. Emeryville, California. January 25, 2002.
“Mysteries of Handwashing”. Presented at the Annual Educational Conference for the Canadian Institute of Public Health Inspectors. Toronto. May 2-3, 2002.
“Waterless Handwash and Gloving”. Presented at the 4th Annual Conference of Windsor-Essex Infection Control and Prevention Committee. Windsor, Ontario. September 19, 2001.
“Reuse of Single-use Medical Devices”. Presented at the 1st International Conference of the South Chile Society of O.R. Nurses & Sterilization. Vina del Mar, Chile. August 29-31, 2001.
“Safe Reprocessing of Narrow Lumened Medical Devices”. Presented at the American Hospital Association Conference. Washington. Aug. 15 - 18, 2001.
“Reprocessing of Flexible Endoscopes; What’s New Up the Wazoo!”. Presented at the American Hospital Association Conference. Washington, D.C. August 15 - 18, 2001.
“Safe Reprocessing of Narrow Lumened Medical Devices”. Presented at the International Federation of Sterile Supply. Kuala Lumpur. Mar 26 - 29, 2001.
“Cleaning Methods and Validation Issues”. Presented at the Recent Advances in Central Service Sterilization Sciences. Kuala Lumpur, Malaysia. March 25, 2001.
“Handwashing, Gloving and Waterless Handwash”. Presented at the Southwestern Ontario Practitioners of Infection control Conference. May 30, 2001.
Anton Andonov
Food and Drug Administration, Blood Products Advisory Committee, 76th Meeting, June19-20, 2003. Gaithersburg, MD, US. “SARS: Canadian studies (epidemiology and virology), implications for blood safety”.
VIII European Congress of the International Society of Blood Transfusion, July 5-9, 2003, Istanbul, Turkey. State of the art lecture; “The virological aspects of SARS Coronavirus”.
Fred Aoki
Sept 21, 2000: Non-HIV viral infection in pregnancy. District VI of the American College of Obstetricians and Gynecologists Annual Meeting, Winnipeg, MB.
May 30, 2001: Influenza vaccines – new developments. Immunization Progress and Challenges 2001, Communicable Disease Control Unit, Manitoba Health’s Immunization Conference, Winnipeg, MB.
Feb 2, 2002: Ontario Thoracic Society Better Breathing Symposium, Toronto, ON.
Feb 10, 2002: Neuraminidase inhibitors: controlled trials. Forum on Respiratory Infections, Monte Carlo.
June 22, 2003: Rabies: Post-exposure Prophylaxis. Canadian Association of Emergency Medicine Physicians, Winnipeg, MB.
Sept 17, 2003: Influenza Immunization for Health Care Workers. WRHA Immunization Conference, Winnipeg, MB.
Jan 31, 2004: Update on Infectious Diseases. Hoffmann-La Roche Ltd., Toronto, ON
Apr 16, 2004: Update on Genital Herpes. Department of Family Medicine, Faculty of Medicine, University of Manitoba, Winnipeg, MB.
Apr 22, 2004: 21st Century Epidemics: Influenza. The Manitoba College of Family Physicians, Winnipeg, MB.
Apr 22, 2004: Pneumococcal Disease in Manitoba and Canada. Manitoba Immunization and Travel Conference, Winnipeg, MB.
Harvey Artsob
2001. Potential benefits of microsystem/nanotechnology in global defence against various forms of bioterrorism. Meeting on Microsystems and Nanotechnology organized by NRC and Microsystems Technology Research Institute, November 11-13, Banff, Alberta.
2002. Plenary summary on Public Health, Preparedness and Response at Meeting on Biological Terrorism: Canadian Research Agenda sponsored by Canadian Institutes of Health Research and Health Canada, January 18-20, Toronto, Ontario.
2002. Zoonotic Disease risks in Canada. Occupational Safety and Health Workshop ‘02, February 27-28, Edmonton, Alberta.
2002. West Nile virus: an exotic virus newly introduced into North America and potential threat to Manitoba. Mid-Canada Section, AOAC International, March 12, Winnipeg, Manitoba.
2002. Incursion of West Nile virus into North America. National Conference of Environmental Health Officers and First Nations, March 25-26, Vancouver, British Columbia.
2002. Lyme disease in Manitoba. Wellness Expo, May 4, Winnipeg, Manitoba.
2002. West Nile virus: can exotic arthropod-borne agents make permanent residence in Canada? UWO Stanier Symposium 2002. Linking Hygiene to Health: Old Foes and New Challenges. May 10, London, Ontario.
2002. Overview of the level 4 facility and work being performed at the National Microbiology Laboratory in Winnipeg. Canadian Laboratory Medicine Congress 2002, May 19-23, Calgary, Alberta.
2002. Canadian activities pertaining to dengue virus diagnostics. Dengue Net meeting coordinated by The Pan American Health Organization. July 9-11, San Juan, Puerto Rico.
2002. Emerging Zoonotic Diseases. October 15, University of Manitoba Bug Day, Winnipeg, Manitoba.
2002. West Nile: a virus no longer exotic to North America. Manitoba Congress of Medical Laboratory Science, October 31-November 2, Winnipeg, Manitoba.
2003. National Microbiology Laboratory smallpox testing preparedness. Smallpox Modelling Think Tank, January 16-17, Aylmer, Quebec.
2003. Canadian activities in response to a possible bioterrorist event. Centre for Defence and Security Studies, February 5, Winnipeg, Manitoba.
2003.West Nile virus - lessons learned in 2002 and preparations for 2003. TIBDN (Toronto Invasive Bacterial Diseases Network) Spring Education Day, March 7, Toronto, Ontario.
2003.West Nile virus in North America: infectious disease history in the making. Manitoba College of Family Physicians Inc, 45th Annual Scientific Assembly, April 10-12, Winnipeg, Manitoba.
2003. West Nile virus. HIV counsellors network meeting. May 22, Winnipeg, Manitoba.
2003. The effect of West Nile virus on the health care system - laboratory testing, a national perspective. Ontario Hospital Association. June 16, Hamilton, Ontario.
2003. West Nile virus update. Annual meeting of Canadian Association of Emergency Physicians, June 14-17, Winnipeg, Manitoba.
2003. The new epidemics - SARS, West Nile virus and mad cow disease. Weizmann Women and Science. Weizmann Canada, September 16, Toronto, Ontario.
2003. The new epidemics - SARS and West Nile virus. The Canadian Society for the Weizmann Institute of Science. September 18, Ottawa, Ontario.
2003. Zoonotic diseases - emerging and re-emerging threats. Manitoba Business of Science Symposium, October 9, Winnipeg, Manitoba.
2003. Emerging zoonotic diseases. American College of Physicians. Manitoba-Saskatchewan chapter scientific meeting. November 1-2, Winnipeg, Manitoba.
2004. West Nile: will this emerging disease impact on British Columbia in 2004? British Columbia West Nile Virus Planning Meeting, January 27, Vancouver, British Columbia.
2004. West Nile virus research and long-term implications should WNV become endemic. First Nations Inuit Health Branch (FNIHB) West Nile Planning Meeting, February 4, Ottawa, Ontario.
2004. Zoonotic Diseases: A Canadian perspective. Ontario Veterinary Medical Association Conference, February 5, Ottawa, Ontario.
2004. West Nile: Biology of an emerging flavivirus. Health Products and Food Branch/Biologics and Genetic Therapies Directorate (HPFB/BGTD) West Nile virus workshop, February 18-19, Aylmer, Quebec.
2004. Status of hygiene: perspectives in relation to emergent and re-emergent infections. Stanier Workshop & Public Discussion meetings, February 26-27, Vancouver, British Columbia.
2004. Vector-borne flaviviral diseases due to West Nile, dengue and yellow fever viruses. Manitoba Immunization & Travel Health Conference, April 22-23, Winnipeg, Manitoba.
2004. Control strategies for emerging zoonotic diseases: implementation of generic safety measures, WHO/FAO/OIE Joint Consultation on Emerging Zoonotic Diseases, May 3-5, Geneva, Switzerland.
2004. Emerging/non-emerging arboviral diseases and the veterinary/public health interface. Canadian Animal Health Laboratories Network 3rd Annual Meeting. May 16-19, Guelph, Ontario.
2004. Bioterrorism Tier 1 laboratory training. Canadian Society of Medical Laboratory Science. June 13-16, Saskatoon, Saskatchewan.
Kathryn Bernard
Bioterrorism: Development of a Canadian Laboratory Response Network- a report to Health Canada managers, U of Manitoba Dep’t Med. Microbiology. Hecla Island July 1, 2001
Bioterrorism: Response to BT Agents and an update of HC NML Activities & the HC WG 56th Int. NW Conference on Diseases in Nature Winnipeg MB July 30, 2001
Bacteriologic agents of bioterrorism. Manitoba Conference of Medical Laboratory Sciences, Brandon MB Oct. 2, 2001
Bacteriologic agents of bioterrorism. Red River College lecture, Winnipeg MB Oct. 11, 2001
Laboratory Response to Bioterrorism. An update from the Health Canada working group CACMID 69th Conjoint Meeting on Infectious Diseases November 7, 2001, Victoria BC
Agents of Bioterrorism: Laboratory Issues 101. In Bioterrorism and Public Health: Investigation and Control CEPR-Health Canada. Dec. 12-13, 2001
Bioterrorism: a Briefing for the Canadian Public Health Laboratory Forum. Winnipeg, MB Nov. 21, 2001
Laboratory Response to Bioterrorism. An update from the Health Canada working group NML /U of Manitoba lecture series Jan. 10, 2002
Biological Agents of Concern. ERAP training workshop, Ottawa Feb.13-15, 2002
Laboratory Response to Anthrax in Environmental Specimens AOAC Mid-Canada meeting Winnipeg MB March 12, 2002
Overview of Laboratory Response to the bacterial agents of Bioterrorism Specimens National Research Council Winnipeg MB April 12, 2002
Bioterrorism 101: part of the Biotech Alive! Lecture Series for senior high school students April 19, 2002
Creating a network of microbiology laboratories for bioterrorism response- the Canadian experience. International Union of Microbiological Societies Paris, France July 28, 2002
G-8 Summit: Lessons Learned. A report to the CPHLN meeting Sept. 19, 2002
Bioterrorism Preparedness in Canada: An update on laboratory planning. CACMID Conference, Halifax NS November 6, 2002
Detection and Triage of bacterial agents of bioterrorism at the Canadian federal reference centre. Biosecurity Summit 2002. Las Vegas, NV. November 19, 2002
Bioterrorism Preparedness in Canada An Overview. Centre for Defence and Security Studies, University of Manitoba Winnipeg MB. Feb. 5, 2003
Agents of Bioterrorism-Laboratory based procedures for Canadian Tier 1 facilities. April 2003, Red River College Winnipeg MB.
Decontamination Issues with the Agents of Bioterrorism- Environment Canada Meeting of CRTI 02-0067RD participants Ottawa Ont. June 26 2003
Bioterrorism: an overview of the higher risk agents and Canadian response options. Part of the symposium, Asymmetric threats: Canada and Beyond. Centre for Defence and Security Studies, University of Manitoba, Winnipeg, MB July 11, 2003
Opportunities for biotechnology in biodefence. Business of Science Symposium, Winnipeg MB Oct. 9 2003
Bioterrorism: roles of Health Canada and members of the CPHLN. Department of Medical Microbiology University of Manitoba, Winnipeg MB Oct 23, 2003
Biological weapons, the environment, human health and bioterrorism response. Environmental Symposium, Queen’s University Kingston Ont. Feb 7 2004
Bioterrorism Overview of the creation of a response network and recognition of Tier 1 agents. Red River College, faculty of Medical Laboratory Technology, as guest lecturer June 2 2004
An overview of Bioterrorism response- Workplace Health and Public Safety Programme Visit by federal officers. June 25 2004 at the NML, Winnipeg.
Revisiting the genus Corynebacterium with emphasis on C. diphtheriae. Dep’t Medical Microbiology, U of Manitoba, Winnipeg MB Feb. 6, 2002
Corynebacterium species Queen’s University-Kingston General Hospital, Kingston Ont Feb 6 2004
Review of Corynebacterium diphtheriae or C. ulcerans isolates in Canada from cases which were not consistent with notifiable disease criteria. L De Winter and K. Bernard (presented by LDW), 8th international meeting of the European Working Group on Diphtheria. June 16-18, 2004 Copenhagen Denmark
Jody Berry
(2002) Novel Strategies for the rapid generation of monoclonal antibodies. University of Manitoba Dean of Medicine Quarterly Research Forum. Canadian Science Centre for Human and Animal Health. Winnipeg, February 8.
(2002) The Monoclonal Antibody Facility at the National Centre for Foreign Animal Disease. Red River Community College, Winnipeg, October 22.
(2003) Antibody Libraries from Immune Repertoires: The development of monoclonal Antibody to Infectious Agents. Faculty Research Seminar. Department of Medical Microbiology, University of Manitoba. January 29.
(2003) The Development of Recombinant Monoclonal Antibodies (MAbs) for Treatment and Detection of BioTerrorism Agents [BTA]. CRTI Spring Symposium. June 25. Chateau Gatineau, QE.
(2003) Therapeutic monoclonal antibodies to SARS coronavirus. Current Science of SARS symposium, National Microbiology Laboratory, Winnipeg, Manitoba, Canada.December 1.
(2004) The Development of recombinant monoclonal antibodies for the treatment and detection of Bio-terrorism agents. Biological and Chemical Defence review committee, National Microbiology Laboratory, Winnipeg, Manitoba, Canada, May 6.
(2004) Immunochemistry and genetics of monoclonal antibodies to SARS-CoV. The National Microbiology Laboratory, Winnipeg, Manitoba, Canada, June 7.
(2004) From the SARS virus to Anthrax toxins: How can we slay these monsters by exploiting host antibody responses? The Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada, June 10.
James Blanchard
July, 2001: “Populations, pathogens and epidemic phases: closing the gap between theory and practices in STI/HIV prevention”. Division of STD Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA.
February, 2002: “Strategic considerations for STI/HIV prevention in India”. Center for AIDS Prevention Studies, University of California San Francisco, San Francisco, CA.
July, 2003: “Sex work in India: patterns embedded in societal tradition”. International Society of STD Research Annual Conference, Ottawa, ONT.
July, 2003: “A tale of two States: differentiating between epidemic phase and transmission dynamics in the Indian States of Rajasthan and Karnataka. International Society of STD Research Annual Conference, Ottawa, ONT.
Stephanie Booth
Department of Animal Sciences and Industry, Kansas State University. Invited seminar on “Prion Diseases: Pathogenesis and Diagnosis”, (2004).
Timothy Booth
Pandemic Influenza: Assessing capabilities for prevention and response. Institute of Medicine, The National Academies, Washington D.C., June 16 2004.
"Laboratory diagnosis of SARS". Current Science of SARS Symposium, Winnipeg, Canada, December 2, 2003.
"2004 H7N3 avian influenza outbreak in British Columbia, Canada" November 21st, 2004,
St. Judes Hospital, Memphis, Tennessee.
"The NML experience with SARS in Canada", British Columbia Centre for Disease Control,
July 18th 2003.
Eric Bow
Feb 22-24, 2002. 2002 Tandem BMT Meetings (IBMTR/ABMTR/ASBMT), Orlando, FLORIDA
Symposium: New Perspectives in the Management of Fungal Infections in Immunocompromised Hosts
“Antifungal prophylaxis in Leukaemia Patients”
Mar 3-5, 2002. Symposium, San Diego, CA “Treating Fungal Infections”
Mar 22-25, 2002. EBMT, 28th Annual Meeting, Geneva, SWITZERLAND Symposium: Managing Serious Fungal Infections in the BMT Patient “Serious Fungal Infections in the BMT Setting: Overview and Epidemiology”
April 17-18, 2002. Conference on Myocet, Montreal, QUEBEC “Side Effects of Chemotherapy: Gut Absorption Model”
May 4-7, 2002. 4th European Congress of Chemotherapy and Infection, 9th Biennial Conference on Antiinfective Agents and Chemotherapy, Paris, FRANCE Symposium: Antifungal Therapy: A New Dimension. “Prophylaxis and empirical therapy in patients at risk for serious fungal infections”
May30-Jun 2. 8th Annual CBMTG Meeting, Halifax, NOVA SCOTIA. “New Treatments in the Treatment of Mucositis”
Sep 27-30, 2002. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, CA. Session: Approaches to the Management of Infections in Cancer Patients: An Evidence-Based Approach. “Antibacterial Prophylaxis in an Era of Multi-Drug Resistance: Targeting the Right Patient at the Right Time”
Oct 30-31, 2002. Visiting Speaker to the Divisions of Infectious Diseases and Hematology, Department of Medicine, Dalhousie University, Halifax, NOVA SCOTIA. “My Mouth Hurts, My Bum Hurts, and I Want to go Home”. “Sorry, No Beds! You’ll Have to go Home (Monotherapy of Febrile Neutropenia)”
Nov 15-16, 2002. Invited Speaker: Scientific Meeting with Haematologists in Japan, Osaka, JAPAN
“Prevention of Invasive Fungal Infection in Neutropaenic Cancer Patients: Can a milligram of Prevention Result in a Kilogram of Cure?”
Dec 6-10, 2002. American Society of Hematology (ASH) Annual Meeting, Philadelphia, PA. Meet-the-Expert Session with Japanese Haematologists
Jan 30-Feb 3, 2003. Tandem BMT Meetings (IBMTR, ABMTR, ASBMT), Keystone, CO Session: Transplant Center Resources. “Canadian Analysis of Required Resources for Transplant Centres”
Mar 7, 2003. CIDS/CAMM Weekend 2003, Quebec, QUEBEC. Symposium: Invasive Fungal Infections: Focus on Aspergillosis Interactive Case Presentations
Apr 16, 2003. Provincial Lymphoma/Leukaemia Rounds, Saskatoon Cancer Centre, Saskatoon, SK.
“A Little Learning is a Dangerous Thing … Infection Prevention in Neutropaenic Cancer Patients and Haematopoietic Stem Cell Transplants”
Sept 11, 2003. Princess Margaret Hospital Conference, Toronto, ON. Satellite Symposium: Emerging Therapy for Supportive Care in Cancer Patients. “Changing Treatment Options for Serious Fungal Infections in Oncology”
Sept 14-17, 2003. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, ILLINOIS. “Efficacy of Piperacillin/Tazobactam as Initial Empiric Therapy of Febrile Neutropenia in Patients with Hematologic Malignancy”
Sept 20-21, 2003. 7th Atlantic Canada Hematology/Oncology Symposium, Dalhousie University, Lunenberg, NS. “Infections and Cancer”
Oct 18-19, 2003. Canadian Fungal Infections Consensus Forum, Scottsdale, AZ. “Treatment and Management of Fungal Infections in Neutropenic Patients”
October 22, 2003. Infectious Diseases Rounds, The Ottawa Hospital, Civic Campus. “Treatment of Invasive Fungal Infections in the Immunocompromised Cancer Pateint; Prophylactic Therapy vs. Empiric Therapy vs. Pre-emptive Therapy vs. Directed Therapy … this is really confusing!”
Nov 12-14, 2003. Serious Fungal Infection Forum, Budapest, HUNGARY. “Antifungal Prophylaxis”
Dec 6-9, 2003. American Society of Hematology (ASH) Annual Meeting, San Diego, CA. “Efficacy of Piperacillin/Tazobactam as Initial Empiric Therapy of Febrile Neutropenia in Patients with Hematologic Malignancy”
Jan 19, 2004. Canadian Association of Nurses in Oncology, Winnipeg, MB. “Invasive Fungal Diseases and Treatment”
Jan 31, 2004. Antifungal Treatments in 2004, Nyborg, DENMARK. “Treatment of Invasive Fungal Infection in the Immunocompromised Cancer Patient”
Mar 11, 2004. Presentation to Section of Infectious Diseases and Section of Haematology/Oncology, Department of Internal Medicine, University of Manitoba. “Recent Developments in the Management of Invasive Fungal Infections in Cancer Patients Receiving Intensive Cytotoxic and Immunosuppressive Therapy”
Mar 28, 2004. 30th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT), Barcelona, SPAIN. Symposium: First Things First: Managing Serious Fungal Infections in the BMT Patient
“Strategies for Early Antifungal Therapy in the BMT Setting”
May 1, 2004. 14th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Prague, CZECH REPUBLIC. Satellite Symposium: New Considerations in the Management of Serious Infections Utilising Appropriate Antibiotic Therapy to Improve Outcomes While Minimising Increases in Antibiotic Resistance. “Focus on Current Therapeutic Alternatives for Febrile Neutropenia”
May 26-27, 2004. ID / Haem Rounds, Victoria General Hospital, Halifax, Nova Scotia. “Management of the Febrile Neutropaenic Cancer Patient: Whose Guideline is it anyway?”
June 22, 2004. Infectious Diseases/Microbiology Rounds. Sunnybrook Hospital & Women’s College Health Sciences Centre, Toronto. “Of Yeasts and Hyphae … Management of Fungal Infections in Cancer Patients”
Jingxin Cao
Symposium of Emerging Viral Disease Control, Chinese Academy of Sciences, Wuhan, China, Oct.14-15, 2004. Evaluation of MVA Based recombinant SARS vaccines in ferrets.
Michael Carpenter
2004, “Proteomic Analysis of Hepatitis C virus gene expression”, Department of Internal Medicine, University of Manitoba, Winnipeg, MB
Clifford Clark
Canadian Institute of Public Health Inspectors Conference, Winnipeg, Sept. 16 – 17, 2004
NRC Campylobacter Symposium, Ottawa, April 28 – 29, 2003.
Third Symposium on DNA-based Serotype Identification of Enteric Bacteria, CDC, Atlanta, Georgia, March 28, 2002
PulseNet Planning Meeting for DNA Sequencing-based Subtyping, CDC, Atlanta, Georgia, Jan 17-18, 2002
FTPCFSP-CCMOH Joint Session on Investigation of Foodborne Illness Outbreaks, Victoria, BC, Nov 14, 2001
International Conference on Diseases in Nature Communicable to Man. August, 2001, Winnipeg, MB.
Kevin Coombs
(2002). Assembly and disassembly of reovirus; from genetics to MALDI TOF mass spectrometry. Department of Microbiology and Immunology, University of Western Ontario, London, March 21.
(2002). Reovirus assembly and disassembly, from reassortant genetics to MALDI Qq-TOF mass spectrometry. Department of Microbiology and Infectious Diseases, University of Calgary, Calgary, May 13.
Michael Drebot
West Nile Virus Workshop , Jamaica, Detection of an emerging Pathogen, March 2003
Diagnostics Workshop CACMID, West Nile virus: Diagnosis and Testing Algorithms, Montreal, 2003
Surveillance for West Nile Virus, Cuba, March 2004
Infection Session, Cell Blood, Marrow, Tissue Group, West Nile virus: Establishment of an exotic virus in North America and its implications for Canada, London Ontario, June 2004.
John Embil
Infection Control: Avoiding the Fire Before It Starts! Canadian Burn Nurses Association Annual General Meeting, Winnipeg, Manitoba. September 23, 2001
Pneumonia: Hospital and Community Acquired – Up, Close and interactive with Dr. Taraska and Dr. Embil. Victoria General Hospital Medical Grand Rounds, Winnipeg, Manitoba. September 28, 2001.
Infection Control Issues in Longterm Care. Geriatric Nursing Interest Series. Riverview Health Center, October 11, 2001.
Bugs, Drugs and Rock and Roll. “Wonders of Woundcare Wisdom Conference”. Fort Garry Place, Winnipeg, Manitoba. October 12, 2001.
The Bug Stops Here! Medical Grand Rounds, Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada. October 16, 2001.
Community Acquired Pneumonia . 4th Annual Conference: Clinical Advances in Infectious Diseases . Victoria, British Columbia, November 10, 2001.
The Diabetic Foot, An Update. 4th Annual Conference: Clinical Advances in Infectious Diseases. Victoria, British Columbia, November 10, 2001.
Case Histories in Infectious Diseases. University of Manitoba, Continuing Medical Education Program, Boundary Trails Health Centre, Morden, Manitoba, December 13, 2001.
5 Minutes on the 5-minute Case Report. 12th Annual Canadian Internal Medicine Chief Residents’ Conference. Fairmont Winnipeg, Winnipeg, Manitoba. February 8, 2002
Infectious Diseases. Southeastman Region (Steinbach) Educational Session sponsored by the University of Manitoba Continuing Medical Education Department. February 19, 2002.
City of Winnipeg, Surgical Grand Rounds: The Superbugs are Here! Do you Know What to Do? Theatre C, University of Manitoba, February 20, 2002.
Antibiotic Resistance Issues in the Hospital. Moxifloxacin in the Hospital: A Hospital Pharmacist Regional Advisory Board Program. The Fairmont Hotel Vancouver, Vancouver, British Columbia. February 23, 2002.
Infectious Diseases: Community Acquired Pneumonia, the Diabetic Foot and Other Cases. University of Manitoba Continuing Medical Education Program, Swan River, Manitoba. March 5, 2002.
Seven Oaks General Hospital Grand Rounds: MRSA – The New Nightmare. Seven Oaks General Hospital, Winnipeg, Manitoba. March 7, 2002.
Infectious Diseases in Action. Bottom Line Business Club. Wildwood Country Club, Winnipeg, Manitoba. March 14, 2002.
Infectious Diseases: A Case Based Discussion. Surgical Network Meeting of the Northwestern Ontario Medical Society, Dryden, Ontario. March 21, 2002.
Surgical Site Infections and Antimicrobial Prophylaxis. A Case Based Discussion. Surgical Network Meeting of the Northwestern Ontario Medical Society, Dryden, Ontario, March 22, 2002.
Managing the Diabetic Foot. Surgical Network Meeting of the Northwestern Ontario Medical Society, Dryden, Ontario, March 22, 2002.
Infectious Diseases. Emergency Medicine Update. University of Manitoba Continuing Medical Education Program, Winnipeg, Manitoba. March 23, 2002.
Prescribing Footwear for Highrisk Diabetics. “The Business of Pedorthics”. Annual General Meeting of the Pedorthic Association of Canada. Vancouver, British Columbia, April 12 – 14, 2002.
Prevention and Management of Foot Complications in Persons with Diabetes. Diabetes Education Day for Central Region Health Authority Inc. Westside Community Church, Morden, Manitoba, April 17, 2002.
Diabetic Foot Ulcers. 2nd Annual Provincial Dialysis Program Education Symposium. May 25, 2002, Canad Inn, Regent Avenue, Winnipeg, Manitoba.
Surgical Infections in Antibiotic. A Continuing Education Session for Surgical Residents. May 29, 2002, Winnipeg, Manitoba.
When Things Get Hot. Serious Infections Effective Intervention Strategy Symposium. June 1, 2002, Royal York Hotel, Toronto, Ontario.
The Scoop on Poop: Clostridium difficile Associated Disease. Annual General Meeting of the Community and Hospital Infection Control Association (CHICA), Manitoba Chapter. June 14, 2002, Italian Cultural Centre, Winnipeg, Manitoba.
Regional Intelligence: Manitoba to British Columbia. New Challenges, Trends and Controversies in Gram-Positive Infections. June 22, 2002, Vancouver, British Columbia
MRSA Decolonization versus Non- Colonization: A Debate. New Challenges, Trends and Controversies in Gram-Positive Infections. June 22, 2002, Vancouver, British Columbia.
Case Histories in Infectious Diseases: An Interactive Discussion. Pine Falls and Surrounding Area Family Physician Continuing Medical Education. October 3, 2002.
An Update of the Diabetic Foot. Clinical Research Nursing Network Annual Conference. Gimli, Manitoba, October 5, 2002.
Wound Management. Southeastman Region (Steinbach). Educational Session sponsored by the University of Manitoba Continuing Medical Education Department. October 10, 2002.
The Bugs Amongst Us. Medical Grand Rounds, Department of Medicine, University of Manitoba, Winnipeg, Manitoba. October 15, 2002.
The Diabetic Foot: Treatment Challenges. Manitoba Renal Program Annual Conference. St. Boniface General Hospital, Winnipeg, Manitoba, October 17, 2002.
The Diabetic Foot. Continuing Medical Education for Family Physicians, University of Manitoba, Theatre A, Health Sciences Centre, November 1, 2002.
Training Session for Clinical Trials Studies Monitors: Intra-abdominal Sepsis. Toronto, Ontario, November 18, 2002.
Training Session for Clinical Trials Studies Monitors: Skin and Soft Tissue Infections. Toronto, Ontario, November 18, 2002.
The Role of Infection in Healing of Diabetic Foot Wounds. Consensus Meeting on Woundcare Recommendations for the Diabetic Foot. Lisse, The Netherlands, November 22-24, 2002.
Town Hall Forum: Blastomycosis. Kenora, Ontario, November 27, 2002.
Blastomycosis: State of the Art. Grand Rounds, Lake of the Woods District Hospital. Kenora, Ontario, November 28, 2002.
Infectious Diseases. University of Manitoba Continuing Medical Education Program for Primary Care Physicians. The Pas, Manitoba, November 29, 2002.
Infectious Diseases in Action, Medical Grand Rounds, St. Boniface General Hospital, Winnipeg, Manitoba, January 16, 2003 .
Infectious Diseases. Central Region – Educational Session hosted by University of Manitoba. Boundary Trails Health Centre, Morden, Manitoba, February 13, 2003.
Management of Skin and Soft Tissue Infections. Victoria Hospital Medical Grand Rounds, February 14, 2003.
An Update in Antimicrobial Therapy for Plastic Surgeons. Plastic Surgery Academic Half-Day,. Winnipeg, Manitoba, March 12, 2003.
Case Studies in Infectious Diseases and Medical Microbiology, Red River College, Winnipeg, Manitoba, March 13, 2003.
Case Studies in Infectious Diseases. Family Medicine Teaching Rounds. Portage la Prairie, Manitoba, March 13, 2003.
Cocaine: Not All Its Cracked Up to Be! Resident Research Day, Department of Internal Medicine, University of Manitoba, April 23, 2003.
Anterior Neck Mass: An Unusual Presentation of Blastomycosis. Resident Research Day, Department of Internal Medicine, University of Manitoba, April 23, 2003.
Therapeutic Update: Antibiotics in Action. University of Manitoba Continuing Medical Education for Family Physicians, Winnipeg, Manitoba, May 2, 2003.
How Do We Know if a Wound is Infected? 4th International Symposium on the Diabetic Foot, Noordwijkerhout, The Netherlands, May 23, 2003.
Determinants of Health, invited presentation for course Issues in Health, Course #88.2305/3, University of Winnipeg, Winnipeg, Manitoba, June 4, 2003.
The Bug Stops Here!! 2003 Operating Room Nurses Association of Canada National Conference. Winnipeg, Manitoba, June 9, 2003.
At Home with Superbugs, MRSA and VRE. Annual Conference of the Community and Hospital Infection Control Association of Canada. Deer Lodge Centre, Winnipeg, Manitoba. June 13, 2003.
Necrotizing Fasciitis and Skin and Soft Tissue Infections. Canadian Association of Emergency Physicians Annual General Meeting, Winnipeg, Manitoba. June 17, 2003.
Key Note Address: Superbugs and You! Mid-Canada Association of Analytical Chemists, Winnipeg, Manitoba. June 19, 2003.
A Hole in One! Case Studies in Infectious Diseases. A Continuing Medical Education Session for Rural Family Physicians. Quarry Oaks Golf Course, Steinbach, Manitoba, July 11, 2003.
Chairman, Complicated Infections Round Table Discussion. Chicago, IL September 16, 2003.
Community Acquired Infections: Round Table Discussion. A Continuing Medical Education Program for Urban Family Physicians. Winnipeg, Manitoba, September 24, 2003.
Case Discussions in Public Health and Community Medicine. Northwestern Health Unit Bug Day, Kenora, Ontario, September 26, 2003.
Hospital and Community Acquired Infections Case Discussions. College of Registered Nurses of Manitoba, Interlake Electoral District. Lakeview Resort, Gimli, Manitoba, September 27, 2003.
Determinants of Health, invited presentation for course Issues in Health, Course #88.2305/3, University of Winnipeg, Winnipeg, Manitoba, October 1, 2003.
Infectious Diseases Case Histories. A Continuing Medical Education Program for Family Physicians. Dryden, Ontario, October 1, 2003.
The Bugs and You: Infectious Diseases in Action. Emergency Care 2003, The Emergency Department Nurses Association of Manitoba. Radisson Hotel, Winnipeg, Manitoba, October 8, 2003.
A Day in the Life of the Health Sciences Centre: Infectious Diseases Management. Continuing Education for Family Physicians. Steinbach, Manitoba, October 10, 2003.
Antibiotics in Primary Care. An Educational Session for Nurse Clinicians. Health Sciences Centre, Winnipeg, Manitoba, October 15, 2003.
Medical Grand Rounds, University of Manitoba: What a Year! Infection Prevention and Control in Action. University of Manitoba, Winnipeg, Manitoba, October 21, 2003.
Health Talk: Infectious Diseases. St. John’s Ravenscourt School, Winnipeg, Manitoba, October 27, 2003.
An Office Infection Control in the Era of SARS. American College of Physicians, Manitoba-Saskatchewan Chapter Scientific Meeting, Winnipeg, Manitoba, November 1, 2003.
Antibiotic Update. American College of Physicians, Manitoba-Saskatchewan Chapter Scientific Meeting, Winnipeg, Manitoba, November 1, 2003
Infection Control in the Office Setting: How to Keep and your Patients Safe in the Era of MRSA and SARS. Infectious Diseases Update. Hot Topics and Recent Advances, Victoria, British Columbia, November 7, 2003.
Management of Fever in the Postoperative Patient. Hot Topics and Recent Advances, Victoria, British Columbia, November 7, 2003.
Investigating and Management of Bone and Joint Infections. Hot Topics and Recent Advances, Victoria, British Columbia, November 8, 2003.
Wound Infection and its Impact on Dressing Selection/Healing – Researchers Viewpoint. Wounds – UK, Harrogate International Conference Centre, Harrogate, UK, November 11, 2003.
Infectious Diseases Cases in Laboratory Medicine. Presentation at the Annual General Meeting at the Manitoba Society of Laboratory Technologists, Winnipeg, Manitoba, November 18, 2003.
Prevention and Care, The Financial and Human Costs. MLA’s Breakfast, Diabetes Awareness Breakfast, Manitoba Legislature, November 24, 2003.
First Year Family Medicine Resident Academic Half Day: Infectious Diseases Emergency. Kildonan Medical Centre, Seven Oaks General Hospital, January 12, 2004.
Refresher on Meropenem. AstraZeneca Annual General Sales Meeting. Miami, Florida. January 14, 2004.
A View from the Trenches – Infectious Diseases Cases. Continuing Education Presentation. Cadham Provincial Laboratory, Winnipeg, Manitoba, January 29, 2004.
The Bad Beasties: SARS, Panama Flu, MRSA…Winnipeg Children’s Hospital, the 4th Annual Pediatric Nursing Conference: Practicing for a Change… Changes in Practice. March 5, 2004.
Infectious Diseases in Action: A Look at Medicine from the Microbe and Physician. 7th Annual Rotary Career Symposium. Winnipeg, Manitoba March 24, 2004.
Management of Infections in Otolaryngology: A Case Based Overview. Winnipeg, Manitoba, March 25,
Look What Walked Through the Door! Case Histories in Infectious Diseases and Medical Microbiology. University of Western Ontario/London Health Sciences Centre, Clinical Microbiology and Infectious Diseases Rounds. London, Ontario, March 31, 2004.
Look What Walked Through the Door! Case Histories in Infectious Diseases and Medical Microbiology. Emergency Medicine Grand Rounds, University of Western Ontario/London Health Sciences Centre, London, Ontario, April 1, 2004.
Insulin Injection Site Abscess with Mycobacterium fortuitum , Department of Internal Medicine Resident Research Days, Winnipeg, Manitoba, April 13, 2004.
Osteonecrosis of the Jaw Associated with Pamidronate Therapy. Department of Internal Medicine Resident Research Days, Winnipeg, Manitoba, April 13, 2004.
Round Table Discussion: Antimicrobial Agents for the Management of Respiratory Tract Disease. Thunder Bay, Ontario, April 13, 2004.
Coughing Up the Truth About SARS and Other Bugs. The Critical Eye, Focus on Respiratory Care. Winnipeg, Manitoba, April 19, 2004.
Sensible Prescribing of Antibiotics in the Age of the “Resistant Bug”: A View from the Trenches. Family Medicine: Issues and Updates 2004, Annual Scientific Assembly and Business Meeting of the Manitoba College of Family Physicians, April 22, 2004.
Assessment and Management of Diabetic Foot Problems. Family Medicine: Issues and Updates 2004, Annual Scientific Assembly and Business Meeting of the Manitoba College of Family Physicians, April 24, 2004.
Infectious Diseases Issues in Chronic Renal Failure. The Other Side of the Bed: A Journey Through Chronic Kidney Disease. Manitoba Renal Program, April 26, 2004.
Lower extremity Morbidity in Persons with Diabetes and Endstage Renal Disease. 10th Malvern Diabetic Foot Conference, Malvern UK, May 13, 2004.
Look What Walked through the Door: Case Histories. Infectious Diseases for Critical Care Nurses. Critical Nurses Association of Canada. Manitoba Chapter, Annual General Meeting, Winnipeg, Manitoba, May 17, 2004.
Look What Walked through the Door, Cased based Discussion about Polymicrobial Infections. Winnipeg, Manitoba, June 3, 2004.
Joanne Embree
HIV Infection in Children. What have we learned in 20 years? Royal College of Physicians and Surgeons of Canada Speaker. 11th International Paediatric Infectious Diseases Conference, Banff, Canada, February 6-9, 2002.
Influenza Infections in Children. Are we helping our children properly? Royal College of Physicians and Surgeons of Canada Speaker. 11th International Paediatric Infectious Diseases Conference, Banff, Canada, February 6-9, 2002.
Perinatal HIV Infection. What we’ve learned in 15 years. 10th Annual Western Perinatal Research Meeting, Banff, Canada, February 14-17, 2002.
Vaccinations in children and adolescents: Making an educated judgement. Satellite Symposium, 79th Canadian Paediatric Society Meeting. Toronto, Canada, June 12-16, 2002.
Pneumococcal Conjugate Vaccine. 5th Canadian National Immunization Conference. Victoria, Canada December 1-3, 2002.
Perinatal HIV: Difficult Decisions. Canadian Infectious Diseases Society – Canadian Association of Medical Microbiologists Weekend 2003. Quebec, Canada, March 7-10, 2003.
Rapporteur Session: Making the Connections – Epidemiology and Public Health. 12th Annual Canadian Conference on HIV/AIDS Research. Halifax, Canada, April 9-12, 2003.
STDs from cradle to grave. Pediatric Grand Rounds. Texas Children’s Hospital, Baylor College of Medicine, Houston Texas, Jan 16, 2004.
Pertussis Disease in Teens. Manitoba Immunization and Travel Health Conference. Winnipeg, Manitoba, April 22-23, 2004.
STDs from Cradle to Grave: An update for pediatricians. Satellite Symposium, 81st Canadian Paediatric Society Meeting. Montreal, Canada, June 16-20, 2004.
What’s New in the Red Book. 81st Canadian Paediatric Society Meeting. Montreal, Canada, June 16-20, 2004.
Heinrich Feldmann
Filovirus pathogenesis. Scripps Institute, La Jolla, California, U.S.A.
Emerging viral zoonoses. Jahrestagung der Gesellschaft für Virologie, Dresden.
Filoviruses and hantaviruses: recent advances inmolecular biology, epidemiology and pathogenesis. 3rd International Conference on Emerging Zoonoses, Noordwijkerhout, Holland.
Emerging and re-emerging viral diseases. Tagung der ‚Deutschen Vereinigung zur Bekaempfung der Viruskrankheiten‘ und der ‚Gesellschaft fuer Virologie‘, Berlin, Germany.
Hantaviruses of the Americas. European Meeting on Viral Zoonoses, St. Raphael, France
Glycoproteins of hemorrhagic fever viruses: biosynthesis, processing, function and role in pathogenesis. Department of Cell Biology, University of Alberta, Edmonton, Canada.
Glycoproteins of hemorrhagic fever viruses: biosynthesis, processing, function and role in pathogenesis. Colloquium of Frontiers of Infectious Disease and Tropical Medicine, The University of Texas Medical Branch, Galveston, Texas, USA.
Molecular Pathogenesis of viral hemorrhagic fevers. Univeristy of Wuerzburg, Germany
Hantaviruses: Molecular biology and epidemiology. University of Montreal, Montreal, Canada
Molecular pathogenesis of filoviruses (Marburg and Ebola viruses). Department of Microbiology and Immunology, Dalhousie University, Halifax, Canada
Special Pathogens Program: Current applied and basic research. The Dean of Medicine Research Forum, University of Manitoba, Winnipeg, Canada
Molecular pathogenesis of viral hemorrhagic fevers. Institute of Virology, University of Wuerzburg, Germany
Glycoproteins of hemorrhagic fever viruses: biosynthesis, structure, function and role in pathogenesis. Department of Microbiology and Immunology, University of British Columbia, Vancouver, Canada
Viral and host factors in the pathogenesis of Marburg and Ebola hemorrhagic fevers. Emory University, Yerkes Primate Center, Atlanta, USA
Molecular pathogenesis of viral hemorrhagic fevers exemplified by Ebola virus. Robarts Research Institute, London, Ontario, Canada.
Viral hemorrhagic fevers – exotic maladies woth global impact. XIIth International Congress of Virology, Paris, France (state of the art lecture).
Marburg and Ebola viruses: The glycoproteins in pathogenesis and host defense. Department of Microbiology, Iowa State University
Viral hemorrhagic fevers – exotic maladies with global impact. United States Department of Agriculture, Ames, Iowa, USA.
Marburg and Ebola viruses. World Medical Association. Washington, DC, USA
Marburg and Ebola viruses: The pathogens and their interaction with the host immune system. 33. Annual Meeting of the German Society of Immunology, Marburg, Germany.
Marburg and Ebola viruses: the pathogens and their interaction with the host immune system. 33. Annual Meeting of the German Society of Immunology. Marburg, Germany.
Marburg and Ebola viruses: the pathogenesis and their interaction with the host. The Awaji International Forum on Infection and Immunity. Awaji Island, Japan.
Non-replicating and replicating vectors. Symposium ’Infections of the Endothelium’. Dresden, Germany.
Ebola hemorrhagic fever: the role of the glycoproteins in pathogenesis and host defense. 4th International Conference on Emerging Zoonoses. Ames, Iowa, United States.
Replicating vectors for vaccine devlopment. VRC Symposium on Viral Hemnorrhagic Fevers. Bethesda, United States
Severe acute respiratory syndrome (SARS): getting prepared for the re-emergence. University of Montreal, Quebec, Canada
Virusbedingte haemorrhagiscge Fieber: Herausforderung an die Wissenschaft und das Gesundheitswesen. Philipps-University, Marburg, Germany
Replicating vectors protects against lethal Ebola virus challenge. American Society for Microbiology. Biodefense Workshop, Baltimore, USA.
Marburg and Ebola viruses: determinats of pathogenesis and host immune response. McLaughlin Symposium, Galveston, Texas, USA.
Reverse genetics and pathogenesis studies. National Institutes of Allergy and Infectious Diseases (NISAID), Biodefense Workshop, Bethesda, Maryland, USA.
Filoviral hemorrhagic fever: overview. National Institutes of Allergy and Infectious Diseases (NISAID), Biodefense Workshop, Bethesda, Maryland, USA.
Special Pathogens Program. AOAC, Winnipeg, Canada.
Marburg and Ebola viruses. Threat of Infection. Leopoldiner Symposium, Wuerzburg, Germany
Update on field lab diagnosis techniques for Ebola. World Health Organization Workshop on Viral Hemorrhagic Fevers. Paris, France
Keith Fowke
HIV Resistance and Disease Susceptibility. Dept of
Pharmacology, University of Manitoba, Jan 11, 2002.
HIV disease progression and HIV resistance? Depr of Immunology, University of Manitoba, Apri11, 2002.
Why some individuals are resistant to HIV infection? 2002 Correctional Nurses Workshop, Winnipeg, May 3 2002.
The Role of Immune Activation in HIV Disease Progression. Manitoba Health Research Council 20th Anniversary Symposium. Principal Investigator Basic Science Lecture. Nov 14, 2002.
HIV Resistance in Kenyan Commercial Sex Workers. United Nations Association in Canada/Sage House. Dec 4, 2002.
Genetic Susceptibility to HIV Infection. Department of Biochemistry and Medical Genetics Lecture Series. Dec 11, 2002.
International Infectious Disease Research at the University of Manitoba. Orientation for Government of Canada Foreign Service Recruits, Office of International Liaison, University of Manitoba. April 21, 2003.
Natural Immunity to HIV Infection: Lessons in Experiment of Nature. Keystone Symposium on 20 Years of HIV Research. Banff, Alberta April 2, 2003.
The Immunology of Resistance to HIV infection. Memorial University of Newfoundland Immunology Group Visiting Professor. Nov. 5, 2003, St. John’s Newfoundland.
The Viral Immunology Lab and What We Do. Kiwanis Club of East Kildonan, Feb. 23, 2004, Winnipeg.
The Impact of HIV in Developing Nations. United Nations Association in Canada. Faith Academy High School, Senior 3-4’s International Studies class. March 24, 2004.
The International Centre for Infectious Disease National Training Program – an Overview. Deans for Graduate Studies, Faculties of Medicine ACMC, Winnipeg, June 10, 2004.
Gregory Hammond
Pandemic Influenza, January 2001
The Science and the Magic of Implementing Effective Influenza Prevention Programs, Bug Day, Oct 2001.
Overview of the National Immunization Strategy to the Council of Chief Medical Officers of Health, November 2001
Pandemic Influenza, November 2001
Flu Update - Bug Day, Winnipeg, October 2002
Canada's National Immunization Strategy - From Vision to Action, presented by Dr. Arlene King and Dr. Greg Hammond, November 2002.
National Immunization Strategy, presented to the Advisory Committee on Population Health, October 24, 2003, in Charlottetown, PEI
Promoting Immunization Among Health Care Professional, presented at the Canadian National Immunization Conference in Victoria BC, December 2003.
SARS presentation at Medical Grand Rounds, Winnipeg, with Drs. Frank Plummer/Joel Kettner on April 29, 2003
Implementation of Manitoba's STD Strategy - Winnipeg, June 2003.
Emergency Room Triage and other Respiratory Viral Diseases, Emergency Medicine Conference, Winnipeg, MB, June 2003
Emerging Public Health Perspectives on Nutrition at the Manitoba Business Science Symposium, Winnipeg, MB, October 2003.
Overview of C. difficile, presented at the C. difficile Surveillance Project Symposium, Winnipeg, MB, October, 2003.
C. difficile – Manitoba Study , presented at Bug Day, Winnipeg, MB, October 22, 2003
A Booster on Adult Immunization, presented at the American College of Physicians, Manitoba-Saskatchewan Scientific meeting at the Fort Garry Hotel on November 1-2 2003.
The Challenge and Opportunities of Implementing Geographic Information Systems (GIS) in a Public Health Setting, presented by Chris Greene and Greg Hammond on November 7 at the Department of Community Health Sciences, University of Manitoba.
Influenza 2003: Changes and Challenges, presented at St. Boniface General Hospital Grand Rounds on Thursday, December 18, 2003 in Winnipeg MB.
Careers in Public Health, presented at 7th Annual Rotary Career Symposium, March 23, 2004, Winnipeg Convention Centre.
Manitoba Syphilis Outbreak, presented at Health Sciences Centre, Department of Medicine in Winnipeg at Grand Rounds on Tuesday, May 4, 2003 with Drs. Pierre Plourde and Fred Aoki
Kent HayGlass
Genetics Institute, Boston. July 2001.
World Asthma Meeting, Chicago USA, July 2001
Univ. of Calgary Immunology Research Group: Allergic Diseases Retreat. Sept 2001
Univ of Vienna, FWF (~Austrian CIHR) Visit Sept 2001
Grand Rounds, Pediatrics. Univ British Columbia Oct 2001
Can Soc for Immunology Symposium, Allergy and Asthma: Genetic Susceptibility through Molecular Regulation to Population Health April 2002 . Symposium organizer an Chair
McGill University, April 2002 Meakins Christie Research Inst
Collegium Internatinoale Allergologicum (CIA) Bermuda Oct. 2003
INSERM-454 Montpellier France March 2003
Organizer (with Drs Yang and Embree): International Symposium on the Hygiene Hypothesis, Winnipeg, May 2003.
Opening Plenary Session Speaker, World Allergy Organization triennial meeting, Vancouver 2003
Meakins Christie McGill Asthma Retreat: January 2004. Chateau Bromont
International Congress of Immunology Invited talk, Montreal Canada July 2004
CIA Meeting, Bornholm Denmark August 2004
Runtao He
June 2004. Beijing University. Beijing, PR China. Inhibition of SARS-CoV by aurintricarboxylic acid
June 2004. Chinese Academy of Sciences. Multimerization of SARS-CoV nucleocapsid protein.
Daryl Hoban
Sept 2003 – Proctor & Gamble – Detroit, MI – urologists – 2 presentations
Oct 2003 – Bristol-Myers Squibb – Calgary, AB – fam physicians/RTI – 3 talks
Nov 2003 – Aventis – Dauphin, MB – family physicians/RTI – 1 talk
Nov 2003 – Bristol-Myers Squibb – Thunder Bay, ON – fam physicians/RTI – 1 talk
Nov 2003 – Aventis Pharma – Ottawa/Kingston, ON – fam physicians/RTI – 2 talks
Nov 2003 – Bristol-Myers Squibb – Thompson, MB – fam physicians/RTI – 1 talk
Dec 2003 – Aventis Pharma – Regina, SK – family physicians/ID – 4 presentations
Dec 2003 – Janssen-Ortho – Toronto, ON – training for reps – 1 presentation
Feb 2004 – Aventis Pharma – BC Tour – family physicians – 8 talks
Feb 2004 – Aventis Pharma – Calgary/Edmonton, AB – family physicians – 9 talks
Mar 2004 – Bristol-Myers Squibb – Calg/Edmon, AB – family physicians – 6 talks
Apr 2004 – Bristol-Myers Squibb – Ontario Tour – family physicians – 4 talks
Apr 2004 – Aventis Pharma – Calgary, AB – family physicians – 1 talk
Apr 2004 – Aventis Pharma – Toronto, ON – family physicians – 1 talk
Apr 2004 – Aventis Pharma – Southern Ontario – family physicians – 6 talks
May 2004 – Aventis Pharma – Gimli, MB – family physicians – 1 talk
May 2004 – Aventis Pharma – Vancouver, BC – family physicians – 1 talk
May 2004 – Bristol-Myers Squibb – Toronto, ON – pediatricians – 1 talk
May 2004 – Bristol-Myers Squibb – Calgary, AB – CIDS – 2 talks
June 2004 – Aventis Pharma – Elkhorn – family physicians/RTI – 1 talk
Wendy Johnson
University of Manitoba, Department of Pharmacology – 02/2004
University of Ottawa, Department of Biology – 05/2003
David Knox
“Prostate to Prions”, University of Ottawa, Ottawa, 2003
“Interferon Responsive Gene Expression in Rodent Models of TSE Disease”. Atomic Energy of Canada
Ltd., Chalk River Laboratories, ChalkRiver, Ontario.
Barbara Law
Immunization Update Pediatric Preceptorship Program in Infectious Diseases CME Event, sponsored by Pfizer. Attended by Winnipeg pediatricians.. Nov 17, 2001
Impact, management and prevention of perinatal Varicella Zoster Virus infection: Before and after Varicella Zoster virus vaccine. Feb 15, 2002. 10th Annual Western Perinatal Research Meeting, Feb 14-17, 2002. Banff, Alberta
Pediatric Immunizations. Minnedosa, Mb. Oct 29, 2002. (2hrs)
The Vaccine Solution to Antimicrobial resistance: The Canadian Perspective. Victoria, B.C. Dec 1/ 02. (Wyeth-Ayerst satellite symposium to CNIC. Section 1 Accredited Group Learning Activity for MOCOMP. B.Law chaired the session and presented 1 of 3 lectures.
Vaccine Update. U. Manitoba sponsored CME session, Lake of the Woods Hospital, Kenora, Ontario. May 1, 2003
Workshop on vaccine Safety and Risk-Communication. (1.5 hrs) Canadian Public Health Association, 94th Annual meeting. Calgary, June 10, 2003. B.L. sole presenter
Workshop on vaccine Safety and Risk-Communication. (1.5 hrs) Canadian Pediatric Society, annual meeting. Calgary, June 18, 2003. B.L. and Scott Halperin presenters.
Rationale to Fund VZV Universal Immunization Program Montreal Sept7, 2001
Epidemiology of RSV Disease Paris, France. Oct 4, 2001. Presentation to French neonatologists. Sponsored by Abbott International.
Epidemiology of RSV Disease Dublin, Ireland. Oct 5, 2001. Presentation to Irish Pediatrics group, monthly meeting. Sponsored by Abbott International.
Epidemiology of RSV Disease . Athens, Greece. Oct 7, 2001. Presentation to Greek Pediatricians and Neonatologists. Sponsored by Abbott International.
So you want to work in clinical research: An introductory, interactive workshop in clinical research. Red River College, Oct 27, 2001. Participated in panel discussion on Clinical Trial career opportunities, from the point of a principal investigator in clinical trials.
Immunization Update: focus on varicella; Family Practice Group, Carmel Clinic. Dec 6, 2001
Rationale for VZV Immunization Program Presentation to NIS Program and Planning Committee Meeting on February 23, 2002
Vaccine update: New conjugate vaccines to prevent Meningococcal and Pneumococcal infections; Varicella vaccine. March 6, 2002. Noon hour presentation to Manitoba clinic pediatricians. Sponsored by Merck Canada.
Immunization Update: Varicella vaccine and new conjugate vaccines to prevent Meningococcal and Pneumococcal infection in children. Pediatricians, Family Practitioners, Public Health physicians. Dinner meeting, Brandon April 10, 2002. Sponsored by Merck Canada and Wyeth Ayerst.
Immunization update, Winnipeg Clinic Pediatric group. Dinner meeting, May 7, 2002. Sponsored by Merck Canada and Wyeth Ayerst.
Immunization Update: focus on varicella; Family Practice Group – Seven Oaks Hospital, Winnipeg, June 25, 2002. Sponsored by Merck Canada.
Varicella: how much do we really know about disease burden? Presentation and workshop held as part of symposium, Vaccination for all life stages: Crawling, Walking, Chatting. Barcelona, Spain. Sept 8-10, 2002. Sponsored by GlaxoSmithKline.
Varicella vaccine: impact of knowledge, attitudes and behaviors on vaccine uptake. GSK varicella vaccine consultants advisory group, Toronto, Sept 20, 2002. sponsored by GSK. BL acted as chair.
ACCA (Advisory Committee on Causality Assessment). Plenary Session, Moving Forward: Affirming Vaccine Safety, Canada’s National Immunization Strategy: From Vision to Action. 5th National immunization Conference, Victoria, BC. Dec 1-3, 2002.
Vaccinology Research Training Program, Plenary Session, Research and Professional Education, Canada’s National Immunization Strategy: From Vision to Action. 5th National immunization Conference, Victoria, BC. Dec 1-3, 2002.
Varicella vaccine trends. Lecture in Vaccinology Short Course, University of Berlin with support from GSK. Advanced 1-week module for students taking a masters of Public health at university of Berlin. Rixensaart, Belgium. Jan 12-17, 2003. (and conducted 4 1 hr workshops on immunization program planning and implementation).
Varicella vaccination. Why vaccinate for a benign disease? Royal Vancouver Yacht Club, Vancouver B.C., sponsored by GSK. May 26, 2003
Varicella update Special Rounds, Lions Gate Hospital, sponsored by GSK. May 29, 2003
Update on Immunization Risk-Benefit Communication. Grand Rounds, Royal Columbian Hospital, sponsored by GSK. May 30, 2003
Risk of hospitalization for RSV LRI among infants born between 33-35 completed weeks gestation. Presented as part of Abbott Laboratories Satellite Symposium “What's New in RSV Prophylaxis and Bacterial Resistance in Respiratory Tract Infections?” 80th Annual Meeting of the Canadian Pediatric Society Calgary, AB June 20, 2003.
Vaccine Controversies and Immunization. What’s ID got to do with it? Oct 19, 2003, Banff, Alberta. Western ID Group Annual Retreat.
Risk Factors for Respiratory Syncytial Virus Lower Respiratory Tract Infection Hospitalization in Premature Infants of 33 to 35 Weeks Gestation Oct 20, 2003, Calgary Alberta. Respirology – Neonatal palivizumab clinic program group.
PICNIC study of Risk Factors for RSV Lower Respiratory Tract Infection Hospitalizations in Premature Infants of 33 to 35 Completed Weeks Gestation, Abbott International Satellite Symposium, at Neonatal Hot Topics, Washington D.C. Dec8/03
Yan Li
Genetic analysis and epidemiology of human metapneumovirus isolated in Canada during the 2001-2002 season, Cadham Provincial Laboratory, MB. Sept.4, 2002
Characterization of the new human metapneumovirus isolated in Canada, Provincial Laboratory for Public Health, Edmonton, AB.(January 30, 2003).
Rapid detection and characterization of amantadine-resistant influenza A viruses, Provincial Laboratory for Public Health, Calgary, AB. (January 31, 2003).
Molecular biology and immune responses to SARS-CoV. Health Canada International Workshop on Regulatory Issues Associated with the Development and Lincensing of SARS Vaccines and Immunotherapy Products, Ottawa, Canada (Aug. 18-19, 2003).
Identification and characterization of a novel coronavirus associated with severe acute respiratory syndrome in Canada. Medical Microbiology SARS mini symposium, The University of Manitoba (Sept. 24, 2003).
Current SARS Research.in NML. Current Science of SARS Symposium, Co-sponsored by Health Canada and the Canadian Institutes of Health Research (CIHR), Winnipeg, Manitoba (December 1-2, 2003).
Bruce Light
Advances in Critical Care for Internists. Presented at the Canadian Society of Internal Medicine Annual Scientific Meeting. Banff, Alberta, Oct. 18, 2001
Evaluation of Pulmonary Infiltrates in the ICU. Presented at the Dalhousie ICU Infection Forum, Halifax, NS May 22, 2002
Grant McClarty
Medical Research Council, Banjul, The Gambia, 2004
Annual Symposium "Enzymes in Deoxyribonucleotide Synthesis", 2004, Hemavan, Lapland
Seminar Series, London School of Hygiene and Tropical Medicine, London, England, 2004
National Institutes of Health, Rocky Mountain Laboratories Visiting Scientist Seminar Series, Hamilton, Montana, 2003.
Chlamydia Basic Research Society Annual Meeting, Memphis, Tennessee, 2003
Seminar Series, London School of Hygiene and Tropical Medicine, London England, 2002
Annual Symposium "Enzymes in Deoxyribonucleotide Synthesis", 2002, Stockholm, Sweden
Chlamydia Basic Research Society Annual Meeting, Tuscon Arizona, 2002
Seminar series, Department of Microbiology, University of Texas Health Sciences Center at San Antonio, San Antonio, Texas, 2002
Seminar series, Department of Microbiology and Immunology, University of West Virginia, 2001
Chester Morris
Business exchange on AIDS and development (BEAD), London , England, October 2001, HIV care in the workplace.
First International Conference on Inner City Health, Toronto, Canada, October 2002, Health Status of Aboriginal People in the Inner City of Vancouver, Canada
ILAB, US Department of Labour HIV/AIDS in the Workplace Symposium, Washington, DC, November 2002, Workplace HIV/AIDS programs in Malawi.
International HIV/AIDS Alliance, Cape Town South Africa, August, 2003, HIV programming with vulnerable populations in Africa.
ICASA, Nairobi, Kenya, August 2003, Antiretroviral therapy in a primary care clinic in rural South Africa.
ICASA, Nairobi, Kenya, August 2003, Sexual practices in Kenya, is anal sex more prevalent than thought?
ICASA, Nairobi, Kenya, August 2003, HIV programming with sex workers in Africa.
Stephen Moses
Invited speaker, Fifteenth Biennial Congress of the International Society for Sexually Transmitted Disease Research (ISSTDR), Ottawa, Canada, July 27-30, 2003. “Evidence-based planning for HIV/ADS control programming: experience from India”.
Invited speaker, Fifteenth Biennial Congress of the International Society for Sexually Transmitted Disease Research (ISSTDR), Ottawa, Canada, July 27-30, 2003. “Declining sexually transmitted disease and HIV prevalence among antenatal clinic attenders in Nairobi, Kenya, 1992-2002”.
Invited speaker, Thirteenth International Conference on AIDS and STIs in Africa, Nairobi, Kenya, September 21-26, 2003. Round Table Session, Debate about the Routes of HIV Transmission: “Sexual transmission provides a more consistent explanation of the majority of HIV spread in sub-Saharan Africa than harmful injections”.
Invited speaker, Thirteenth International Conference on AIDS and STIs in Africa, Nairobi, Kenya, September 21-26, 2003. Satellite Session, New Frontiers in Targeted HIV Prevention and Care: “Planning sex worker interventions in India: how appropriate are existing intervention models?”.
Michael Mulvey
Extended Spectrum Beta-Lactamase Producers: Beating the blas. International Antiboitic Resistance Symposium (IARS). University of Manitoba. June 8th 2004.
Extended-Spectrum Beta-Lactamases: The Canadian Story. University of Calgary, Medical Microbiology Rounds, Calgary, AB. Feb. 2003.
Molecular Characterization of Salmonella Genomic Island I and Variants in Typhimurium, Agona, and Paratyphi: Is there any connection to Salmonella Newport? MDR Newport Meeting, Centres for Disease Control and Prevention, Atlanta. 2002.
Surveillance for Extended-Spectrum Beta-Lactamases in Canada: Not so bla After All. The Toronto Bacterial Invasive Disease Network, Mount Sinai Hospital, Toronto, ON. 2002.
Emergence of Epidemic MRSA in Canada. Clinical Laboratory Divisional Rounds, Health Sciences Centre, Winnipeg, MB. 2002.
Bioterrorism and the Role of the Nosocomial Infections Laboratory. Animal Disease Research Institute, Lethbridge, AB. 2002.
Lai-King Ng
2004. World Health Organization Global Salm-Surv: Working to reduce foodborne diseases globally. PAHO Annual Antimicrobial Resistance Surveillance Network Meeting, Lima, Peru, June 29-July 1, 2004.
2004. Cultural and non-cultural methods for detecting Shigella from patients and the environment. World Health Organization, Dhaka, Bangladesh, February 12-19, 2004.
2003. Directions for PulseNet Canada - Optimizing the Network. FFSNR, St. Hyacinthe, Québec, October 5-7, 2003.
2003. PulseNet Canada and beyond: real-time surveillance. CPHLN Meeting, Toronto, Ontario, September 10-12, 2003.
2003. Detection of the mechansims of resistance to antimicrobials in N. gonorrhoeae. ICDDR, B-HHMI Infectious Disease Research, Bangladesh, September 8-23, 2003.
2003. Real time quantitative (RT) PCR. ICDDR, B-HHMI Infectious Disease Research, Bangladesh, September 8-23, 2003.
2003. A comparison of snapshot and microarray-based detection of gyrA and parC mutations in ciprofloxacin-resistant N. gonorrhoeae. 2003. International Society for Sexually Transmitted Diseases Research 2003 Congress, Ottawa, July 27-30, 2003.
2003. Mechanisms of antimicrobial resistance in N. gonorrhoeae. Rio de Janeiro, Brazil, June 14-21, 2003.
2003. Surveillance of antimicrobial resistance in the Americas. Pan American Health Organization and Health Canada. Rio de Janeiro, Brazil, June 14-21, 2003.
2003. Results of the Quality Assurance Program. PAHO Annual Meeting. Buenos Aires, Argentina, May 8-11, 2003.
2003. PulseNet Canada and beyond: Real-time Surveillance. 7th Annual PulseNet Update Meeting. San Antonio, Texas, April 28-May 3, 2003.
2003. Mutation associated with macrolide resistance in Neisseria gonorrhoeae. Seminar at the University of Alberta. Edmonton, Alberta, April 19-24, 2003.
2002. Mechanisms of resistance to ciprofloxacin and macrolide in N. gonorrhoeae. Public Health Laboratories, Department of Health, Hong Kong Special Administrative Region, November 2002.
2002. Mutation in 23S rRNA Conferring Macrolide Resistance in Neisseria gonorrhoeae, NML, Winnipeg, Manitoba, September 9, 2002.
Lindsay Nicolle
Invited Speaker: “Emerging infectious diseases” and “HIV/AIDS: The changing prognosis”.
American Academy of Insurance Medicine. 110th Annual Meeting, Ottawa October 9, 2001.
Speaker. “Controlling resistance or controlling infection? California APIC Co-ordinating Council Advanced Conference for Infection Control Practitioners. San Diego October 12, 2001.
Invited Speaker “Healthcare-acquired infections: Hospitals as a breeding ground for antimicrobial resistance” at Workshop: Issues of Resistance; Microbes, Vectors, and the Host. Forum on Emerging Infections. Institute of Medicine, Washington, February 7, 2002.
25th CIDS Weekend, Banff, February 28-March 3, 2002. Discussant: Laboratory-acquired Brucella, March 2. Co-chair: Infection Control Symposium, March 3, 2002.
Invited speaker. Fresh Tracts 2002; Canadian UTI Symposium: Whistler, March 9, 2002. Presentation – “UTI in the Elderly”; Panel – Chronic/Recurrent UTI.
Invited speaker. “Asymptomatic Bacteriuria” at University of Toronto, Division of Geriatric Medicine, Biology of Aging. Baycrest, Toronto, April 12, 2002.
Invited Faculty. Workshop: Infection Prevention in Long Term Care. APIC 2002; 29th Annual Educational Conference and International Meeting, Nashville, May 19, 2002.
CHICA-Canada National Meeting. St. John’s, Newfoundland June 3, 2002. Panel: Rediscovering Infection Control: Long Term Care. Invited speaker: Antibiotic management in long term care.
Program Chair: Managing Acute Uncomplicated Cystitits in Women in the Era of Antibiotic Resistance, Seattle August 2, 2002. Speaker: Keynote Address: The growing concern over antibiotic resistance. Management strategies: Traditional therapies: Back To the Future.
Invited speaker: State-of-the-art Mini-Lecture. Diabetes and Urinary Tract Infection. Co-chair: Urinary Tract Infections Session. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, Sept 30, 2002.
University of Manitoba, Continuing Medical Education for Family Physicians, “Sexually Transmitted Disease” in “Sexual Health” Oct 4, 2002.
Invited speaker: Society of Urologic Surgeons of Ontario. Urinary tract infections in Nursing Homes, Toronto, January 22, 3003.
Invited speaker. X Meeting of the Spanish Society for Infectious Diseases and Clinical Microbiology “Prevention of infections in the elderly” in Symposium: Infections in the Elderly, Oviedo Spain March 26, 2003.
Visiting professor, University of Michigan Sections of Geriatric Medicine and Infectious Diseases, Dept of Internal Medicine, Ann Arbor, May 7,8, 2003. Geriatric Clinical Conference: “The diagnosis of symptomatic UTI in long-term care facilities”. Infectious Disease Grand Rounds “Is asymptomatic bacteriuria a clinical issue?”
Invited speaker, “What is the current epidemiology of UTI’s?” at APUA: UTI treatment at a turning point: Improving antimicrobial prescribing for uncomplicated UTI’s in an era at increasing antibiotic resistance. Boston June 10, 2003.
Invited participant. Panel: Issues and controversies in Long Term Care and Community Infection Control, Thunder Bay, June 23, 2003.
Invited speaker: 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago Sept 14-17, 2003. Symposium: “Significance and management of asymptomatic bacteriuria”. Sept 14. Workshop: “Infection control in long term care facilities. Sept 16.
Invited speaker. Hamad Medical Corporation, Department of Medicine, Doha, Qatar. “Nosocomial Intranmission of Viral Hepatitis Infection” at Hepatology Symposium Nov 1, 2003. “Hospital Infection Control Programs and Controlling Antimicrobial Resistance in Hospitals”. Nov 6, 2003.
Speaker. “Position Paper: Infection control precautions for respiratory infecitons at Health Canada Meeting: Infeciton Control Precautions for Respiratory Infections. Ottawa, Nov 24, 2003.
Invited speaker. “Asymptomatic bacteriuria in diabetic women” at Urologic Complications of Diabetes Workshop. NIDDK, National Institutes of Health, Bethesda, Dec 4, 2003.
Nationwide Teleconference Series: “Managing acute uncomplicated cystitis in women in the era of antibiotic resistance” 2003; Oct 20, 23, 27, Nov 10, 17, 18, 19, Dec 1, 8, 9, 10.
Guest speaker: “Management of lower respiratory infections” St. Amant Centre Tri-Annual Attending Physicians Meeting, Winnipeg, Feb 12, 2004.
Invited speaker: “Urinary Tract Infection in Diabetes” in Symposium: Current Aspects of Urinary Tract Infection Therapy. 11th International Congress of Infectious Diseases, Cancun, Mexico, Mar 7, 2004.
Society for Healthcare Epidemiology of America 14th Annual Scientific Meeting Philadelphia, Pennsylvania
• Meet-the-Consultant: Infection in Long Term Care, April 18, 2004
• Session Chair. Submitted Scientific Papers: Investing Wisely: Infection control in long term care. April 18, 2004
• SHEA Lectureship: A distant shore: Rational antibiotic use in long term care facilities. April 18, 2004.
• Posters with Professional Rounds (invited professor) April 19, 2004.
Invited speaker: “Manuscript writing: Perils and Pitfalls”. CIDS Associate Members Day, Calgary, Alberta, April 28, 2004.
Invited speaker: “Can we improve antibiotic use in the institutionalized elderly?” CIDS/CAMM/CHICA Conjoint Meeting, Calgary, Alberta, April 30, 2004.
Pamela Orr
2001. Invited speaker to Faculty of Medicine, University of Malaysia in Kuching: “New and Old Pathogens in the Canadian North: Meeting the Challenge”.
2001. Invited speaker, Federation of Medical Women. November 2001. “STD Research in the Amazon: Ethical Issues in International Studies”.
2002. Invited panelist, HIV/AIDS Session, 9th International Women and Health Conference, Toronto, August 2002.
2003. Invited speaker, Arctic Institute, University of Oulu, Finland, January 13, 2003. “The Health of Canadian Inuit: Challenges for the 21st Century”.
2003. Invited speaker, Tuberculosis – Elimination or Resurgence, 4th Bi-Annual Spring Conference, Edmonton, March 17-18, 2003. “Facing a tidal wave: the broader implications of dual TB and HIV infection”.
2003. Invited speaker at University of Saskatchewan CME Conference on Infections, October 2003. Two talks: “Seniors and infectious disease – The top 10 things you need to know: Addressing and containing infectious diseases in closed settings”, and “Avoiding infections in seniors: It’s more than just a flu shot”.
1992-2002. Lecturer, Northern Nursing Program, University of Manitoba
2000-2003. Invited lecturer to University of Laos – Case Western University (Health Frontiers) Postgraduate Residency Training Program in Pediatrics. Responsible for creation of a teaching program for Community/Public Health (December 2000, April-May 2001, January 2002)
Rosanna Peeling
June 2001. The International Society for STD Research meeting, Berlin, Germany. The Public Health Impact of Rapid STI Diagnostics: Promises and Challenges.
September 2002. Brazil National Congress for STDs , Manaus, Brazil. Rapid Tests for STDs.
October 2002. 12th International Union STI Asia Pacific Congress, Beijing, China. Rapid Diagnostic Tests for Sexually Transmitted Diseases.
April 2003. 5th International Multidisciplinary Congress of the European Research Organization on Genital Infection and Neoplasia (EUROGIN), Paris, France:
1. Current Issues in Diagnostic Testing of STDs;
2. Gonorrhea and Chlamydiae, New Thoughts on Old Diseases;
3. Rapid Diagnostic Methods for STIs and Future Challenges;
4. Building an STI Control Programme.
May 2003. Global Health Diagnostics Working Group, The Bill & Melinda Gates Foundation, Seattle, U.S:A. Case Studies in Diagnostics.
July 2003. Congress of the International Society for STD Research, Ottawa, Canada. Rapid STI Diagnostics and Their Role in Resource-Constrained Settings.
October 2003. Wellcome Trust meeting on Genomics and Diagnostics, Cambridge, UK. The impact of diagnostics.
December 2003. 8th World STI/AIDS Congress. Punta Del Este, Uruguay.
February 2004. International Conference on Women and Infectious Diseases, Atlanta, USA. Syphilis: an age-old disease that still impacts neonates.
February 2004. WHO workshop on Reproductive health, Shenzhen, China. Rapid STI tests as tools for control and prevention.
April 2004. STI Prevention Group, St. Petersburg, Russia. The utility of rapid tests for STIs.
May 2004. 50th Anniversary of the Chinese National Center for STDs, Nanjing, China. The STD epidemic in China: will rapid tests make a difference?
Pierre Plourde
Information from 2001 not available
Feb 14, 2002 SBGH Medical Grand Rounds (Anthrax)
April 2, 2002 HSC Medical Grand Rounds (Powders and Anthrax)
Oct 15, 2002 HSC Bug Day (What’s All the Itch About – Scabies and Head Lice)
Jan 30, 2003 SBGH Medical Microbiology Rounds (STD Diagnostics – Update and Testing Strategies)
March 14, 2003 Manitoba Association of Environmental Health Officers Conference (Bioterrorism – Microbes as Weapons)
April 25, 2003 Manitoba Travel Health Network Conference (CATMAT Update; Insect Repellents and Insecticides; TB or Not TB)
May 15, 2003 SBGH Transfusion Symposium (West Nile Virus)
June 6, 2003 Alberta Travel Health Association Conference (CATMAT Update; Insect Repellents and Insecticides; What’s New in Travel Vaccines?)
June 13, 2003 CHICA Day (Have Bug Will Travel – Tips for Travellers’ Health)
Oct 21, 2003 HSC Bug Day (Travellers Be Aware! What you need to know to travel)
Nov 18, 2003 Creative Retirement Lecture Series (Emerging Infectious Diseases 2003)
March 20, 2004 Manitoba Association of Asian Physicians Symposium (Refugee Health)
April 23, 2004 Manitoba Travel Health Network Conference (CATMAT Update; Envenomation; A Trip to Haiti in January 2004)
May 4, 2004 HSC Grand Medical Rounds (An Outbreak of Infectious Syphilis in Winnipeg)
May 12, 2004 Annual Manitoba Research Nursing Association Dinner (Travel: What You Need to Know)
May 19, 2004 HSC Medical Microbiology Rounds (An Outbreak of Hepatitis A in a Winnipeg Restaurant)
Francis Plummer
March 24, 2002. Perspective on HIV Therapy in Developing Countries, American Society for Clinical Pharmacology and Therapeutics, 104th Annual Meeting (Invited Speaker)
Nov. 2002. Reception to raise awareness of HIV (focused on Africa), Royal Crown Plaza, Winnipeg, MB (Special guest speaker)
May 20, 2003. “Progress on understanding resisstance to HIV-1 in Sex Workers” - University of Manitoba, Winnipeg, MB (Invited Speaker)
July 27, 2003. International Society for Sexually Transmitted Diseases Research Congress (ISSTDR) - Ottawa, ON (Invited Speaker)
Nov. 26, 2003. “HIV Resistance in Kenyan Sex Workers: Evidence for Naturally Acquired Immunity” - Conference on HIV/AIDS Care in 2003: Thinking Globally, Acting Locally” - The Norwood Hotel - Winnipeg, MB (Guest Speaker)
November 2002. Health Canada Research Forum, Lessons from 20 years of research collaboration between the Universities of Manitoba and Nairobi
November 2003. Health Canada, Chief Scientist’s Distinguished Lecture, Lessons Learned from SARS in Canada, Ottawa
January 2003. South Saskatchewan AIDS Control Program, Epidemics in Our Communities, Regina, Saskatchewan
December 2003. Minnesota State Conference on Emerging Infectious Diseases, SARS: The Canadian Experience, Minneapolis, Minnesota
January 2004. Keystone Conference on Emerging Infectious Diseases, Lessons Learned from SARS in Canada (plenary speaker), Ottawa
Allan Ronald
January 1,2002-June 30, 2004 Visiting Professor, Makerere University when I was responsible for organizing programs for the Academic Alliance for AIDS Care and Prevention under the auspice of Makerere University and the Academic Alliance. This included numerous lectures to groups training in HIV/AIDS.
April 2003 Yale University/ Grace New Haven Hospital: Four presentations during the visit a)Grand Rounds;Responding to African AIDS Epidemic;Dept of Medicine; b)Developing a Research Program Intrasctucture in Africa; c)The Underlying Driving Forces of the AIDS Epidemic.
November 26, 2003 SBGH/HSC – 10th Annual HIV Conference – “Getting ARV’s to Millions – What Is Our Responsibility?”
February 2004 Minnesota A TALE OF TWO CITIES; Infectious Disesase Section, Univ Minnesota
February 26, 2004 Austin, Texas “Tuberculosis and HIV:Duo Terrors in Africa” Internatonal Unilo Against TB.
April 22, 2004 “HIV/AIDS in Africa”, 46th Annual Scientific Assembly (Manitoba College of Family Medicine)
Alberto Severini
Severini A. (2002) [New models of herpesvirus replication] - Institute of Molecular Genetics - Centro Nazionale delle Ricerche - Pavia - Italy - January 30
Graham Tipples
Presentation on "evaluation of measles and rubella serology assays" at the PAHO measles/rubella laboratory network meeting, PAHO technical advisory group, 2 November 2004, Mexico City, Mexico.
Presentation on "lab surveillance of emerging infectious diseases" at the meeting of the Associtation of Public Health Epidemiologists of Ontario, 4 October 2004, Niagara Falls, Ontario.
Presentation on "measles aerosol vaccine characterization study" at the "5th Meeting of the WHO Product Development Group for Measles Aerosol Vaccine", 5-6 April 2004, Geneva, Switzerland.
Presentation on "rubella serology studies" at the "Panel of Experts on Rubella Elimination and Measles Eradication in Latin America and The Caribbean", 3-4 March 2004, Washington, DC, USA.
Presentation on "measles aerosol vaccine characterization study" at the "4th Meeting of the WHO Product Development Group for Aerosol Measles Vaccine", Baltimore, USA, June 19, 2003.
Paul Van Caeseele
Bioterrorism. Manitoba Society of Clinical Chemists Annual Meeting. Winnipeg, November, 2002.
Acanthamoeba keratitis. University of Manitoba Department of Ophthalmology Grand Rounds, Winnipeg, Manitoba, December 2003.
Stefan Wagener
Biocontainment Facilities, Tradeline, 2003, 2004, USA
Containment Level 3 Facilities, OLS, 2003, Ottawa, Canada
Principles & Practices of Biosafety, ABSA, 2003, 2004, USA
Biohazard Containment, TLL, 2004, Singapore
Hana Weingartl
WHO Global Conference on Severe Acute Respiratory Syndrome (SARS): where do we go from here? Kuala Lumpur, Malaysia, June 17 - 18, 2003
Technical meeting on “SARS animal models”, Erasmus University, Rotterdam, Netherlands, February 5 - 6, 2004 (WHO)
John Wylie
Social and sexual networks in Winnipeg. 2004. HIV counsellors network, Winnipeg, Manitoba.
Epidemiology of Methicillin-resistant Staphylococcus aureus in Manitoba. 2004. Continuing Education session, St. Boniface Hospital, Winnipeg, Manitoba.
Spatial/temporal SatScan analysis of Chlamydia trachomatis genotypes. 2004. GIS/spatial analysis group, Community Health Sciences, University of Manitoba, Winnipeg, MB.
New social and molecular tools for public health surveillance and epidemiologic investigations. 2003. Workshop on Social Network Analysis, Field Surveillance Officer Meeting, Health Canada, Ottawa, ON.
New social and molecular tools for addressing sexually transmitted disease epidemiology. 2003. International Society for Sexually Transmitted Diseases Research Congress, Ottawa, ON.
The Winnipeg Social Network Injection Drug Use Study. 2003. Presentation to the STD-Bloodborne pathogen Harm Reduction Working group, Winnipeg Regional Health Authority.
Molecular techniques, social network analysis, and outbreaks. 2003. Workshop on Social Network Analysis, Winnipeg Regional Health Authority and Manitoba Health, Winnipeg, MB. Sponsored by Health Canada.
The Winnipeg Social Network Injection Drug Use Study. 2002. Presentation to Public Health Nurses as part of training program in approaches to Harm Reduction.
The Winnipeg Social Network Injection Drug Use Study. 2002. Injection Drug Use Roundtable, Canadian Centre for Substance Abuse, Ottawa, Ontario.
The Winnipeg Social Network Injection Drug Use Study. 2002. Health Canada and Correctional Services Canada. Partners in Caring conference; comparative issues, barriers, and policies, Winnipeg, Manitoba.
Xi Yang
Invited Speaker, Role of dendritic cells in infection mediated inhibition of allergy, Jinan, Shandong University, 2004
Invited Speaker/Chair: Chlamydial vaccine. International Workshop on Gene Immunization and DNA vaccine, Shanghai, Dec 2003
Invited Speaker: DTH responses in chlamydial infection. Northern Hebei University, Nov 2003
Speaker: Role of dendritic cells in infection mediated inhibition of allergy. International Symposium on Hygiene Hypothesis. University of Manitoba, May 2003.
Invited talk: Immunity to chlamydia: past, present and future. Shandong University, Jinan, April 2003
Invited talk (AHFHR Lectureship Award): Hygiene Hypothesis: Is it supported by experimental studies? University of Alberta. Jan 2002
Invited talk: Cytokine regulation in chlamydial infection. Shandong University, Jinan, Jan 2002
George Zhanel
“Management of respiratory infections in the nursing home” Presented at Geriatric Grand Rounds, Queen Elizabeth II Hospital, Halifax, Nova Scotia, September 5,2001.
“Antibiotic resistance in the maritimes: Implications for management” Presented at Medical Grand Rounds, St. John Hospital, St. John, New Brunswick, September 5,2001.
“Management of community acquired pneumonia in the new millenium” Presented at Medical Grand Rounds, Moncton Hospital, Moncton, New Brunswick, September 6,2001.
“What to do with new antibiotics on the formulary” Presented at Medical Grand Rounds, Sydney General Hospital, Sydney, Nova Scotia, September 6,2001.
“Controversial issues regarding the management of respiratory tract infections” Presented at Medical Grand Rounds, Yarmouth, Nova Scotia, September 6,2001.
“Canadian Respiratory Organism Susceptibility Study: Implications for Prince Edward Island” Presented at Medical Grand Rounds, Queen Elizabeth II Hospital, Charlottetown, Prince Edward Island, September 7,2001.
“Antibiotic resistance and its implications on the management of sinusitis” Presented at Family Physician Update, Winnipeg, Manitoba, September 12,2001.
“Treatment of otitis media in the days of antibiotic resistance” Presented at a Pediatrics Update, Winnipeg, Manitoba, September 13,2001.
“Development of new antibiotics in the treatment of infectious diseases” Presented at a Family Physicians Update, Winnipeg, Manitoba, September 20,2001.
“New fluoroquinolones: Which when why” Presented at a Family Physicians Update, Edmonton, Alberta, September 30,2001.
“Re-evaluating the treatment of infectious diseases in the days of antibiotic resistance” Presented at Medical Grand Rounds, Centre Hopital Universite Laval, Laval, Quebec, October 3,2001.
“Treatment of infectious diseases: Focus on Bacterial Eradication” Presented at Medical Grand Rounds, L’enfant Jesus Hopital, Laval, Quebec, October 3,2001.
“Acute exacerbations of chronic bronchitis: Prevalence clinical significance and treatment options” Presented at the Seminars of respirology of Quebec, Quebec City, Quebec, October 3,2001.
“Antibiotic resistance in respiratory pathogens in Quebec and Canada” Presented at Medical Grand Rounds, CHUM, Montreal, Quebec, October 4,2001.
“Outcomes of infections caused by resistant pathogens” Presented at Medical Grand Rounds, Jewish General, Montreal, Quebec, October 4,2001.
“Treatment of upper respiratory infections” Presented at Family Physicians update, Montreal, Quebec, October 5,2001.
“Antibiotic resistance and antibiotic use” Presented at Family Physicians update, Montreal, Quebec, October 5,2001.
“Clinical implications of antibiotic resistant infections” Presented at Infectious Diseases Symposium, University of Illinois in Chicago, Chicago, Illinois, October 12, 2001.
“Antibiotic resistance in respiratory infections” Presented at Family Physicians Update, Lake Louise, Alberta, October 13, 2001.
“Review of new antibiotics: Whats their role in practice ? ” Presented at Family Physicians Update, Lake Louise, Alberta, October 13, 2001.
“Treatment of infectious diseases in the days of antibiotic resistance ” Presented at Medical Grand Rounds, Lindsay Medical Centre, Lindsay, Ontario, October 16, 2001.
“Importance of bacterial eradication in the treatment of infectious diseases ” Presented at Family Physicians Update, Toronto, Ontario, October 17, 2001.
“Prevention of infections: Importance of vaccination ” Presented at Family Physicians Update, Toronto, Ontario, October 17, 2001.
“Resistant infections in Canada: Development of new antibiotics ” Teleconference for Family Physicians. Regina and Yorkton, Saskatchewan, October 22, 2001.
“Clinical and economic evaluation of fluoroquinolones versus standard treatment for community acquired pneumonia ” Awareness in respiration, Palm Springs, California, October 28, 2001.
“Macrolide resistance in Canada: Future role of macrolides ” Presented at the annual meeting of the Canadian Association of Microbiology and Infectious Diseases (CACMID), Victoria, British Columbia, November 5, 2001.
“New antibiotics on the horizon ” Presented at the Manitoba Pharmaceutical Association annual meeting, Winnipeg, Manitoba, November 7, 2001.
“What is driving the development of new antibiotics ” Teleconference presented at the Rural Manitoba Pharmaceutical Association annual meeting, Winnipeg, Manitoba, November 8, 2001.
“Clinical significance of resistance in chest infections ” Presented at Respirology Grand Rounds. Ottawa General Hospital, Ottawa, Ontario, November 9, 2001.
“How to minimize the development of antibiotic resistance in the treatment of infectious diseases ” Presented at Respirology Club Rounds, Ottawa, Ontario, November 9, 2001.
“Treatment of upper and lower respiratory tract infections: Focus on B-lactams and macrolides ” Presented at Family Physician Update, Ottawa, Ontario, November 10, 2001.
“Antibiotic resistance in British Columbia: Comparison with Canada ” Presented at Respirology/Family Physician Update, Kelowna, British Columbia, November 13, 2001.
“Dissemination of multi-drug resistant Streptococcus pneumoniae globally: Implications for vaccination ” Presented at Medical Grand Rounds, New Westminster Hospital, New Westminster, British Columbia, November 14, 2001.
“The crowded antibiotic formulary: Streamlining or adding antibiotics ” Presented at Medical Grand Rounds, Surrey Hospital, Surrey, British Columbia, November 14, 2001.
“Treatment of acute exacerbations of chronic bronchitis: How to maximize cure ” Presented at Microbiology/Infectious Diseases/ Respirology Update, Vancouver, British Columbia, November 14, 2001.
“Dissemination of multi-drug resistant Streptococcus pneumoniae globally: Implications for vaccination ” Presented at Medical Grand Rounds, New Westminster Hospital, New Westminster, British Columbia, November 14, 2001.
“The Canadian respiratory organism susceptibility study (CROSS) ” Presented at Medical Grand Rounds, Royal Victoria Hospital, Victoria, British Columbia, November 15, 2001.
“Influence of antibiotic resistance on treatment of infectious diseases ” Presented at Family Physician Update, Calgary, Alberta, November 17, 2001.
“Antibiotic resistance in Toronto: What is happening ” Presented at Respirology Grand Rounds, Toronto West Hospital, Toronto, Ontario, November 19, 2001.
“Risk factors for resistant pathogens ” Presented at Medical grand rounds, Humber Hospital, Toronto, Ontario, November 19, 2001.
“Cellular and molecular mechanisms of fluoroquinolone resistance: One step two step ” Presented at infectious diseases/medical microbiology update, Toronto, Ontario, November 19, 2001.
“Will fluoroquinolones turn into cephalosporins ? ” Presented at Family Physician Update, Toronto, Ontario, November 19, 2001.
“The importance of understanding mechanisms of antibiotic resistance ” Presented at Respirology Grand Rounds, St. Joseph’s Hospital, Hamilton, Ontario, November 20, 2001.
“Treatment of infections in critical care setting ” Presented at critical care rounds, Hamilton Hospital, Hamilton, ontario, November 20, 2001.
“Management of infectious diseases: What the family physician needs to know ” Presented at Family physician update, Grimsby, Ontario, November 20, 2001.
“Antibiotic resistance in southern Ontario: Implications for treatment ” Presented at Respirology Grand Rounds, London Health Sciences Centre, London, Ontario, November 21, 2001.
“The role of new antibiotics in the hospitalized patient ” Presented at Infectious Diseases Grand Rounds, London Health Sciences Centre, London, Ontario, November 21, 2001.
“Understanding the clinical relevance of resistance in respiratory infections ” Presented at Family physician update, Cambridge, Ontario, November 21, 2001.
“Bacterial eradication leads to minimization of antibiotic resistance ” Presented at Respirology Update, Toronto, Ontario, December 2, 2001.
“Appropriate antibiotic use: Its worth it ” Presented at Family Physician Update, Toronto, Ontario, December 2, 2001.
“Oxazolidinones: Finally a new class of antibiotics ” Presented at Infectious Diseases update, Winnipeg, Manitoba, December 6, 2001.
“Macrolide resistance in Canada: Incidence of mef/erm from 1997-2001 ” Presented at Infectious Diseases/Microbiology Update, Chicago, Illinois, December 16, 2001.
“New antibiotics: What role do they have for the internist ” Presented at Medical Grand Rounds, Health Sciences Centre, Winnipeg, Manitoba, January 8, 2002.
“What is the future of fluoroquinolones in Canada ” Presented at Fluoroquinolone update, Banff, Alberta, January 10, 2002.
“What is the future of macrolides in Canada ” Presented at macrolide update, Ottawa, Ontario, January 14, 2002.
“Management of community acquired respiratory illness ” Presented at Medical Grand Rounds, Concordia Hospital, Winnipeg, Manitoba, January 17, 2002.
“Treatment of otitis media in the days of antibiotic resistance ” Presented at Pediatric Update, Toronto, Ontario, January 19, 2002.
“Molecular mechanisms of macrolide resistance in S.pneumoniae ” Presented at macrolide update, Bologna, Italy, January 22, 2002.
“Antibiotic resistant infections: Myths and realities ” Presented at Awareness in Respiration (AIR), Cancun, Mexico, January 31, 2002.
“Controversial issues regarding the new fluoroquinolones ” Presented at Awareness in Respiration (AIR), Cancun, Mexico, February 1, 2002.
“Clinical significance of macrolide resistance ” Presented at Awareness in Respiration (AIR), Cancun, Mexico, February 1, 2002.
“How to evaluate new antibiotics ” Presented at Awareness in Respiration (AIR), Cancun, Mexico, February 1, 2002.
“Antibiotic resistant infections: Incidence, clinical implications and treatment ” Presented at a Specialist Conference on Infectious Diseases, Knysna, South Africa, February 14, 2002.
“Why are patients not failing antibiotic treatment despite antibiotic resistance ” Presented at Pharmacy Rounds, Toronto General Hospital, Toronto, Ontario, February 25, 2002.
“What the family physician needs to know about antibiotic resistance ” Presented at Family Physician Update, Toronto, Ontario, February 26, 2002.
Antibiotic resistance in respiratory infections “ Presented at Family Physician Update, Deerhurst, Ontario, March 2, 2002.
“Pharmacokinetics and pharmacodynamics in the treatment of respiratory infections “ Presented at Family Physician Update, Deerhurst, Ontario, March 2, 2002.
“Formulary issues with new antimicrobials “ Presented at Pharmacy Rounds, Ottawa General Hospital, Ottawa, Ontario, March 5, 2002.
“What to do with all these fluoroquinolones “ Presented at Pharmacy Rounds, Ottawa Civic Hospital, Ottawa, Ontario, March 5, 2002.
“Treatment of community acquired pneumonia in the days of antibiotic resistance“ Presented at Family Physician Update, Windsor, Ontario, March 5, 2002.
“How to overcome antibiotic resistance when treating infectious diseases “ Presented at Medical Grand Rounds, Royal Victoria Hospital, Barrie, Ontario, March 6, 2002.
“Prevalence of antibiotic resistance in Canada “ Presented at Medical Grand Rounds, Scarborough Centenary Hospital, Scarborough, Ontario, March 6, 2002.
“Significance of antibiotic resistance in acute exacerbations of chronic bronchitis “ Presented at Family Physician Update, Toronto, Ontario, March 6, 2002.
“Prevalence, significance and treatment of antibiotic resistant infections “ Presented at Medical Grand Rounds, Lakeridge Health, Oshawa, Ontario, March 7, 2002.
“Treatment of respiratory illness in 2002“ Presented at Family Physician Update, Toronto, Ontario, March 7, 2002.
“What to do with the formulary and antimicrobials “ Presented at Pharmacy Rounds, Scarborough General, Scarborough, Ontario, March 7, 2002.
“Antibiotic resistance in family practice: what does it mean ? “ Presented at Family Physician Update, Toronto, Ontario, March 7, 2002.
“Manitoba antibiotic resistance data: Implications for community acquired infections“ Presented at Family Physician Update, Steinbach, Manitoba, March 11, 2002.
“The future of cephalosporins in the treatment of infectious diseases“ Presented at advisory meeting, Montreal, Quebec, March 18, 2002.
“The importance of bacterial eradication in treating infections ? “ Presented at Family Physician Update, Edmonton, Alberta, March 21, 2002.
“Treatment of infectious diseases in the new millenium“ Presented at Family Physician Update, Edmonton, Alberta, March 21,2002.
“New antibiotics for treating infectious diseases“ Presented at Medical Grand Rounds, Camrose Hospital, Camrose, Alberta, March 22, 2002.
“Treatment of otitis media in the days of antibiotic resistance“ Presented at Pediatricians Update, Banff, Alberta, March 23, 2002.
“Treatment of upper respiratory tract infections in the days of antibiotic resistance “ Presented at Family Physician Update, Banff, Alberta, March 23, 2002.
“Development of new antibiotics: What new for family practice “ Presented at Urban Family Physician Program, University of Manitoba, Winnipeg, Manitoba, April 5, 2002.
“Antibiotic resistance is driving the development of new antibiotics “ Presented at Rural Family Physician Program, University of Manitoba, Selkirk, Manitoba, April 9, 2002.
“Ontario data on antibiotic resistance: Implications for treating infections “ Presented at Family Physician Update, Ottawa, Ontario, April 13, 2002.
“Antibiotic resistance and its significance in outcome “ Presented at Family Physician Program, Moncton, New Brunswick, April 19, 2002.
“The role of macrolides in the treatment of community acquired infections “ Presented at Family Physician Program, Moncton, New Brunswick, April 19, 2002.
“The future development of antibiotics: Why are they coming ? “ Presented at Specialist Meeting, Dominican Republic, April 22, 2002.
“Molecular mechanisms of macrolide resistance “ Presented at Specialist Meeting, Toronto, Ontario, April 29, 2002.
“Antibiotic resistance is driving the development of new antibiotics like the ketolides “ Presented at a Respirologist Specialist Meeting, Kelowna, British Columbia, May 4, 2002.
“The global impact of antibiotic resistant infections “ Presented at the Canadian Association of Research Nurses Annual Meeting (Manitoba Branch), Winnipeg, Manitoba, May 14, 2002.
“Treatment of infectious diseases by the family doctor “ Presented at Family Residents Academic half day, Winnipeg, Manitoba, June 3, 2002.
“Research in the Manitoba antibiotic resistance program: Where is the future going ? “ Presented to the Winnipeg Regional Hospital Authority (WRHA), Winnipeg, Manitoba, June 6,2002.
“The role of macrolides in the treatment of infectious diseases: Today and tomorrow “ Presented at a Specialist Meeting, Crete, Greece, June 17,2002.
“Development of Biaxin XL: What role will it play ? “ Presented at 3rd Annual review in Respirology, Kelowna, British Columbia, June 22, 2002.
“Recent data on the status of antibiotic resistance in respiratory infections in Canada “ Presented at 3rd Annual review in Respirology, Kelowna, British Columbia, June 22, 2002.
“Pharmacokinetics and pharmacodynamics: the importance of bacterial eradication “ Presented at 3rd Annual review in Respirology, Kelowna, British Columbia, June 22, 2002.
“The development of the new fluoroquinolones; Why are they here ? “ Presented through medicine teleconference, Memphis, Tennesse, June 25,2002.
“Role of the new fluoroquinolones in the treatment of infectious diseases “ Presented through medicine teleconference, Los Angeles, California, June 27,2002.
“The future of the new fluoroquinolones in the treatment of infectious diseases “ Presented at Bayer preceptorship, Winnipeg, Manitoba, July 9,2002.
“Molecular mechanisms of resistance of fluoroquinolones in Streptococcus pneumoniae “ Presented at fluoroquinolone meeting, Seattle, Washington, August 2,2002.
“Status of antibiotic resistance in Manitoba and Canada” Presented at Manitoba Intravenous Nurses Association Annual Meeting, Winnipeg, Manitoba, September 12,2002.
“New advances in the treatment of infectious diseases” Presented at Medical Grand Rounds, Peterborough General Hospital, Peterborough, Ontario, September 16,2002.
“Antibiotic resistance in infectious diseases: Implications for treatment” Presented at Family Physician Update, Belleville, Ontario, September 17,2002.
“All you want to know about new antibiotics” Presented at Family Physician Update, Belleville, Ontario, September 17,2002.
“Antibiotic resistance in community acquired pneumonia associated with failures: Implications for treatment” Presented at Respirology Rounds, Toronto East General Hospital, Toronto, Ontario, September 17,2002.
“Pharmacokinetics and pharmacodynamics of aminoglycosides and fluoroquinolones: Implications for clinical practice” Presented at train the trainer specialist meeting, San Diego, California, September 26,2002.
“Macrolide resistance in respiratory infections: Prevalence, significance and implications for resistance propagation” Presented at train the trainer specialist meeting, San Diego, California, September 26,2002.
“Importance of bacterial eradication in the treatment of respiratory infections” Presented at update on pulmonary and critical care medicine, Ann Arbor, Michigan, October 1,2002.
“New antibiotics in the treatment of respiratory infections” Presented at update on pulmonary and critical care medicine, Ann Arbor, Michigan, October 1,2002.
“Everything you wanted to know about antibiotic treatment but were afraid to ask” Presented at Family Physician Update, Detroit, Michigan, October 1,2002.
“Molecular mechanisms of macrolide resistance: Dissemination of the macrolide efflux genetic assembly (MEGA) element” Presented at Infectious Diseases Grand Rounds, Henry Ford General Hospital, Detroit, Michigan, October 2,2002.
“Influence of antibiotic resistance on the treatment of infectious diseases” Presented at Specialist Update, Vancouver, British Columbia, October 8,2002.
“Antibiotic resistance in British Columbia: Impact on treatment” Presented at Medical Grand Rounds, St.Paul’s Hospital, Vancouver, British Columbia, October 9,2002.
“Treatment guidelines of respiratory infections in Canada” Presented at Pharmacology Rounds, Royal Columbian Hospital, Vancouver, British Columbia, October 9,2002.
“The Canadian Respiratory Organism Surveillance Study (CROSS)” Presented at Microbiology Rounds, Vancouver General Hospital and Health Sciences Centre, Vancouver, British Columbia, October 9,2002.
“Methods of minimizing antibiotic resistant infections: Importance of bacterial eradication” Presented at Family Physician Update, Vancouver, British Columbia, October 9,2002.
“Treatment of community acquired pneumonia in a community hospital setting” Presented at Medical Grand Rounds, Lions Gate Hospital, Vancouver, British Columbia, October 10,2002.
“Rapid emergence of multi-drug resistant Streptococcus pneumoniae in North America: Dissemination of results clones” Presented at Medical Grand Rounds, Surrey Memorial Hospital, Surrey, British Columbia, October 10,2002.
“Comparison of antibiotic resistance in Canada and central/eastern Europe: Influence on treatment” Presented at Specialist Meeting on Antibiotic Resistant Infections, Prague, Czech Republic, October 15,2002.
“Macrolides: Their role in the empiric treatment of respiratory infections” Presented at Specialist Meeting on Antibiotic Resistant Infections, Brno, Czech Republic, October 16,2002.
“What is driving the development of antibiotic resistant Streptococcus pneumoniae in central/eastern Europe” Presented at Specialist Meeting on Antibiotic Resistant Infections, Ostrava, Czech Republic, October 17,2002.
“Comparison of Canadian and United States community acquired pneumonia guidelines” Presented at Medical Grand Rounds, Salinas Valley Memorial Hospital, SanFrancisco, California, October 22, 2002.
“Fluoroquinolone pharmacokinetics pharmacodynamics microbiology clinical efficacy and safety” Presented to the Quatra Health System Pharmacy Association, SanFrancisco, California, October 22, 2002.
“Antibiotic resistant infections in the United States: Comparison with Canada” Presented to Pulmonology Fellows/Internal Medicine Residents, SanFrancisco, California, October 23, 2002.
“Development of new antibiotics” Presented at Medical Grand Rounds, Mount Diablo Hospital, SanFrancisco, California, October 24, 2002.
“Clinical relevance of antibiotic resistance in treating infectious diseases” Presented at a Specialist Update, SanFrancisco, California, October 24, 2002.
“What to do with all these resistant superbugs” Presented at Pharmacy Rounds, Tacoma Medical Centre, Seattle/Tacoma, Washington, November 4, 2002.
“Treatment of infectious diseases in the days of superbugs” Presented at Specialist Update, Seattle, Washington, November 4, 2002.
“New antibiotics: What to do with the formulary” Presented at Pharmacy Rounds, Harbourview Medical Centre, Seattle, Washington, November 5, 2002.
“Treatment of pneumonia in a community hospital setting” Presented at Medical Grand Rounds, South Tahoe Medical Centre, Tahoe, Nevada, November 6, 2002.
“Antibiotic resistant infections in the United States: Clinical implications” Presented at Specialist Update, Reno, Nevada, November 6, 2002.
“Antibiotic resistance in respiratory infections” Presented at Specialist Review in Respirology, Winnipeg, Manitoba, November 16, 2002.
“Molecular mechanisms of macrolide and fluoroquinolone resistance: Implications for clinical practice” Presented at Specialist Review in Respirology, Winnipeg, Manitoba, November 16, 2002.
“Treatment of community acquired respiratory infections” Presented at Family Physician Update, Winnipeg, Manitoba, November 20, 2002.
“Molecular mechanisms of macrolide and and ketolide resistance” Presented at Specialist Meeting on Macrolides/Ketolides, Vancouver, British Columbia, November 22, 2002.
“Pharmacokinetics and pharmacodynamics of macrolides and ketolides” Presented at Specialist Meeting on Macrolides/Ketolides, Vancouver, British Columbia, November 22, 2002.
“Pharmacokinetics and pharmacodynamics of fluoroquinolones: What is the role of garenoxacin ? ” Presented at the garenoxacin update, Wallingford, Connecticut, November 26, 2002.
“Comparison of ciprofloxacin, levofloxacin, gatifloxacin and moxifloxacin in terms of chemistry, pharmacokinetics, pharmacodynamics and resistance.” Presented at Alberta Teleconference, Winnipeg, Manitoba, November 28, 2002.
“Treatment of respiratory infections with macrolides: Is there a difference ? ” Presented at Macrolides: A critical review of new data, what lies ahead ?, Rome, Italy, December 6, 2002.
“Molecular mechanisms of macrolide resistance: The answer to why are we not seeing macrolide failures?” Presented at Macrolides Forum: Abbott Labs Meeting, Toronto, Manitoba, January 12, 2003.
“Antibiotic resistance in the United States and Canada: Comparison of TRUST and CROSS ” Presented at Specialist Update, Yuba City, California, January 27,2003.
“Treatment of respiratory infections in the United States: Implications if resistant pathogens” Presented at Respirology Club, Stockton, California, January 28,2003.
“Comparison of the CDC, IDSA and Canadian community acquired pneumonia guidelines” Presented at Medical Grand Rounds, Doctors Hospital, Modesto, California, January 29,2003.
“Critical review of the fluoroquinolones in the United States: Comparison of chemistry, mechanisms of action/resistance, pharmacokinetics, pharmacodynamics, clinical trials and adverse effects” Presented at Clinical Pharmacy Update, Fresno, California, January 29,2003.
“The role of pharmaceutical industry in medical education: perspective of a researcher and educator” Presented at the Faculty of Medicine Students Association pharmaceutical industry/medical education symposium. University of Manitoba, Winnipeg, Manitoba, Feb 14, 2003.
“The global concern of antibiotic resistant infection: What can be done ? ” Presented at the Cebu Annual Family Physicians Association Meeting, Cebu City, Phillippines, March 5, 2003.
“The emerging crisis of antibiotic resistant infections: Comparison of Canada and Southeast Asia ” Presented at the Microbiology/Infectious Diseases Society Meeting, Manila, Phillippines, March 6, 2003.
“Solutions to the problem of antibiotic resistant infectious diseases ” Presented at the Phillippine College of Chest Physicians (PCCP) Annual Meeting, Manila, Phillippines, March 7, 2003.
“How to minimize the growing problem of antibiotic resistant infections: Focusing on bacteriological eradication” Presented at the Family Physicians Society Meeting, Manila, Phillippines, March 7, 2003.
“Maximizing pharmacokinetic/pharmacodynamic parameters leads to optimal bacteriological eradication: An innovative method to limit resistance spread ” Presented at Medical Grand Rounds, Castle Medical Center, Honolulu, Hawaii, March 11, 2003.
“Treatment of infections in family practice ” Presented at Family Practice Rounds, Mililani Physicians Centre, Honolulu, Hawaii, March 12, 2003.
“Insuring the fluoroquinolones: A formula for managed care ” Presented at HMSA Insurance group, Honolulu, Hawaii, March 12, 2003.
“Combating antibiotic resistant infections: Solutions and challenges ” Presented at Pharmacy Rounds, Wahiawa General Hospital, Honolulu, Hawaii, March 12, 2003.
“New antimicrobials for the future treatment of infectious diseases ” Presented at Specialist update, Honolulu, Hawaii, March 12, 2003.
“Multi-drug resistant organisms are leading to the development of new antibiotics: Focus on North America ” Presented at Specialist Update, Honolulu, Hawaii, March 13, 2003.
“Prevalence clinical significance and treatment options of antibiotic resistant infections ” Presented at Medical Grand Rounds, Straub Clinic and Hospital, Honolulu, Hawaii, March 14, 2003.
“Pharmacoeconomic issues relating to new antibiotics ” Presented at Pharmacy Rounds, Tripler Medical Center, Honolulu, Hawaii, March 14, 2003.
“Pharmacokinetics and pharmacodynamic properties as well as molecular mechanisms of resistance of new fluoroquinolones ” Presented at a Managed Care Meeting, Dallas, Texas, March 22, 2003.
“What is the role of antibiotics in driving MRSA, VRE and Clostridium difficile colitis ” Presented at a teleconference, Medical and Pharmacy Groups, Western United States, April 1, 2003.
“Antibiotic resistance in Canada compared to Russia: What measures can we impliment ? ” Presented at the CIS Man and Medicine Annual Conference, Moscow, Russia, April 10, 2003.
“Antibiotic use and infection control issues: What can be done ? ” Presented at a teleconference, Medical and Pharmacy Groups, Southern United States, April 17, 2003.
“Comparison of antibiotic resistance between US and Canada: Similarities and differences ” Presented at Specialist Update, Dallas, Texas April 22, 2003.
“Management of multidrug resistant infections ” Presented at Microbiology Rounds, Parkland Hospital, Dallas, Texas, April 23, 2003.
“Vaccination, infection control and appropriate antibiotic use: Methods to control antibiotic resistant infections ” Presented at Medical Grand Rounds, Presbyterian Hospital of Dallas, Dallas, Texas, April 23, 2003.
“Cellular and molecular mechanisms of fluoroquinolone resistance in Streptococcus pneumoniae” Presented at Antibiotic Induced Collateral Damage, Nappa, California, May 3, 2003.
“Influence of antibiotics on the normal colonic flora” Presented at Antibiotic Induced Collateral Damage, Nappa, California, May 3, 2003.
“The role of cephalosporins in the treatment of respiratory infections” Presented at a teleconference, Family Physicians, Manitoba/Saskatchewan, May 21, 2003.
“The role of cephalosporins and macrolides in the treatment of respiratory infections” Presented at a teleconference, Family Physicians, Ontario, May 22, 2003.
“Antibiotic resistant infections in Canada: What can be done” Presented at a teleconference, Family Physicians, Ontario, May 28, 2003.
“Antibiotic resistance in urinary tract infections: Comparison between Canada and the US ” Presented Urinary Tract Infection Update, Toronto, Ontario, May 31, 2003.
“Antibiotic resistant infections in Ontario vs. Canada ” Presented at a teleconference, Family Physicians, Ontario, June 2, 2003.
“Relationship between macrolide use and macrolide resistance in Canada” Presented at a Family Physician Update, Winnipeg, Manitoba, June 11, 2003.
“Relationship between macrolide use and macrolide resistance in Canada” Presented at a Family Physician Update, Winnipeg, Manitoba, June 11, 2003.
“Importance of bacterial eradication in the prevention of antibiotic resistant infections” Presented at the Canadian Association of Emergency Physicians (CAPE) Annual Meeting, Winnipeg, Manitoba, June 12, 2003.
“Appropriate antibiotic use in general practice ” Presented at a teleconference, Family Physicians, Manitoba/Ontario, June 16, 2003.
“Treatment of otitis media in the days of antibiotic resistance” Presented at the Canadian Society of Pediatrics Annual Meeting, Calgary, Alberta, June 17, 2003.
“Appropriate antibiotic use in family practice: Will it minimize resistance? ” Presented at a teleconference, Family Physicians, Ontario, June 25, 2003.
“Appropriate antibiotic use in general practice: Will it improve outcome? “ Presented at a teleconference, Family Physicians, British Columbia/Ontario, June 26, 2003.
“A review of the new fluoroquinolones: Where does IV moxifloxacin fit in ? ” Presented at a Bayer preceptorship meeting, Winnipeg, Manitoba, July 15, 2003.
“Gatifloxacin-induced glucose alterations: Analysis of published cases ” Presented at a Bayer preceptorship meeting, Winnipeg, Manitoba, July 15, 2003.
“Molecular mechanisms of fluoroquinolone resistance in Streptococcus pneumoniae ” Presented at a ICAAC symposium on antibiotic induced collateral damage, Chicago, Illinois, September 13, 2003.
“Macrolides: Are there any differences ? ” Presented at a ICAAC symposium on antimicrobial resistance in respiratory infections: Clinical implications and impact on optimizing therapy, Chicago, Illinois, September 14, 2003.
“Microbiology, infectious diseases and antibiotics: Review of basic principles ” Presented to Cancer Care Nursing, Winnipeg, Manitoba, September 22, 2003.
“What is driving antibiotic resistant infections in Canada ? ” Presented at a teleconference, Family Physicians, Maritimes and Ontario, October 1, 2003.
“Telithromycin: A new ketolide, what role will it play ? ” Presented to Winnipeg Specialists, Winnipeg, Manitoba, October 2, 2003.
“The clinical relevance of antibiotic resistance in community practice” Presented at Family Physician Rounds, Credit Valley Hospital Clinic, Toronto, Ontario, October 6, 2003.
“How to treat infectious diseases in community practice in the days of antibiotic resistant infections” Presented at Family Physician Rounds, Hamilton, Ontario, October 6, 2003.
“Importance of bacterial eradication in the treatment of infectious diseases” Presented at Medical Grand Rounds, Brantford General Hospital, Brantford, Ontario, October 7, 2003.
“Antibiotic resistance in respiratory infections in Canada: How do we compare with other countries ?” Presented at Family Physician Update, Niagara Falls, Ontario, October 7, 2003.
“Role of pharmacokinetics and pharmacodynamics in the treatment of infectious diseases” Presented at Family Physician Update, Kitchener/Waterloo, Ontario, October 7, 2003.
“What is driving penicillin, macrolide, and fluoroquinolone resistance in Canada and the United States ?” Presented at Emergency Grand Rounds, Hamilton General Hospital, Hamilton, Ontario, October 8, 2003.
“Maximizing pharmacodynamics in the treatment of respiratory infections ?” Presented at Specialist Update, Detroit, Michigan October 8, 2003.
“An evidenced based review of the fluoroquinolones ” Presented at Medical Grand Rounds Sinai Grace Hospital, Detroit , Michigan October 9, 2003.
“The role of cephalosporins in the treatment of infectious diseses: How has resistance impacted on their outcome ? ” Presented at a teleconference, Family Physicians, Western Canada, October 14, 2003.
“Bacterial killing is the new goal in the treatment of infectious diseases ” Presented at a Specialist Meeting, Cannes, France, October 17, 2003.
“Treatment of infectious diseases in the family practice setting ” Presented at Family Medicine Resident Rounds, University of Oklahoma Medical Centre, Oklahoma City, Oklahoma, October 21, 2003.
“Comparison of antibiotic resistance rates between North America, South America, Europe and the Far East: Why such differences ? ” Presented at a Specialist Update, Oklahoma City, Oklahoma, October 21, 2003.
“Innovative ways to combat the growing problem of antibiotic resistant infections in hospitals ” Presented at Medical Grand Rounds, St. John’s Hospital, Tulsa, Oklahoma, October 22, 2003.
“Pharmacokinetics and pharmacodynamics of antibiotics: Can they help us in the treatment of infectious diseases ? Presented at Medical Grand Rounds, Tulsa Regional Medical Centre, Tulsa, Oklahoma, October 22, 2003.
“Treatment of infectious diseases in Canada and the United States: Similarities and differences ? ” Presented at a Specialist Update, Tulsa, Oklahoma, October 22, 2003.
“How to decide what to put on the formulary ” Presented to a Specialist Update Teleconference, Montreal, Quebec, December 2, 2003.
“A critical review of the new ketolides: What role will they play in the treatment of infectious diseases “ Presented at Medical Grand Rounds, Concordia Hospital, Winnipeg, Manitoba, December 4, 2003.
“What is driving the development of antibiotic resistant pathogens around the world ? “ Presented at an International Infectious Disease Meeting, Florence, Italy, December 6, 2003.
“The new ketolides: Review of chemistry, microbiology, mechanisms of action and resistance, pharmacokinetics and pharmacodynamics, clinical trials and adverse effects “ Presented at a Specialist Update, Winnipeg, Manitoba, December 8, 2003.
“How to solve the antibiotic resistance crisis “ Presented at Medical Grand Rounds, Royal Victoria Hospital, Saskatoon, Saskatchewan, December 9, 2003.
“Solutions to the global problem of antibiotic resistant infections “ Presented at a Family Physician Update, Saskatoon, Saskatchewan, December 9, 2003.
“Comparison of the macrolides and the ketolides “ Presented at a Family Physician Update, Regina, Saskatchewan, December 10, 2003.
“What is the future of macrolides “ Presented at an Abbott Antiinfective Meeting, Montreal, Quebec, January 8, 2004.
“Treatment of otitis media: Impact of vaccination on resistance evolution “ Presented at a Pediatric Update, Winnipeg, Manitoba, January 22, 2004.
“What is the clinical relevance of resistance to penicillins and cephalosporins “ Presented at a Specialist Update, Winnipeg, Manitoba, February 2, 2004.
“What role will ketolides have in the treatment of infectious diseases “ Presented at Infectious Diseases Rounds, Vancouver General Hospital and Health Sciences Centre, Vancouver, British Columbia, February 9, 2004.
“Impact of antibiotic resistance in the treatment of infectious diseases “ Presented at Internal Medicine Resident Rounds, Vancouver General Hospital and Health Sciences Centre, Vancouver, British Columbia, February 9, 2004.
“What is driving the development of antibiotic resistant infections in Canada “ Presented at a Family Physicians Update, Vancouver, British Columbia, February 9, 2004.
“Development of new antibiotics: What is driving their development “ Presented at Medical Grand Rounds, Surrey Memorial Hospital, Surrey, British Columbia, February 10, 2004.
“Antibiotic resistance in Canada: Current status “ Presented at a Specialist Update, Kelowna, British Columbia, February 10, 2004.
“Treatment of respiratory infections in the emergency setting “ Presented at a Specialist Update, Kelowna, British Columbia, February 11, 2004.
“The future of antibiotic use and resistance “ Presented at a Specialist Update, Regina, Saskatchewan, February 12, 2004.
“Optimizing pharmacokinetic and pharmacodynamic properties when using antibiotics “ Presented at a Specialist Update, Orlando, Florida, February 18, 2004.
“Treating infectious diseases in the days of antibiotic resistant infections “ Presented at a Family Physician Update, Winkler, Manitoba, February 24, 2004.
“Management of respiratory infections in the days of antibiotic resistant infections “ Presented at a Family Physician Update, Brandon, Manitoba, February 24, 2004.
“A review of new antibiotics on the horizon “ Presented at Medical Grand Rounds, St. Boniface Hospital, Winnipeg, Manitoba, February 26, 2004.
“Treatment of infectious diseases in the days of multi-drug resistant pathogens “ Presented at Specialist Update, Winnipeg, Manitoba, March 2, 2004.
“Pharmacodynamic activity of fluoroquinolones against Bacteroides fragilis simulating achievable serum and stool concentrations “ Presented at the Council on Appropriate Use of Antimicrobials, Cancun , Mexico, March 5, 2004.
“Can we optimize the use of antibiotics to minimize the development and spread of resistant pathogens “ Presented to the Manitoba Drug Standards and Therapeutics Committee (MDSTC), Winnipeg, Manitoba, March 9, 2004.
“What is the future of antimicrobials ? “ Presented at Grand Rounds, Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, March 19, 2004.
“The future of antibiotic resistant infections “ Presented at Graduate and Fellows Recognition Graduation, Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA, April 14, 2004.
“Development and future use of antibiotics in the treatment of infectious diseases“ Presented at Surgery Rounds, Department of Surgery, Regions Medical Center, St. Paul, Minnesota, USA, April 15, 2004.
“Pharmacokinetics and pharmacodynamics of macrolides and ketolides against respiratory pathogens“ Presented at a Ketolide Symposium, Toronto, Ontario, April 16, 2004.
“Pharmacokinetics and pharmacodynamics of macrolides and ketolides against respiratory pathogens“ Presented at a Ketolide Symposium, Toronto, Ontario, April 16, 2004.
“The global battle against antibiotic resistant pathogens: Strategies that we can use “ Presented at the East Asian Conference on Infectious Diseases, Hong Kong, April 23, 2004.
“Maximizing antibiotic pharmacodynamic properties to influence infection outcome and minimize resistance development “ Presented at the Hong Kong Society of Family Physicians Annual Meeting, Hong Kong, April 24, 2004.
“Antibiotic resistant infections in the surgical setting: Focus on infection control and appropriate antibiotic use “ Presented at Surgical Nursing Rounds, Department of Surgery, Heath Sciences Centre, Winnipeg, Manitoba, April 28, 2004.
“High dose fluoroquinolones: Pharmacokinetics/pharmacodynamics and safety considerations “ Presented at the Canadian Infectious Diseases Society (CIDS) annual meeting, Calgary, Alberta, April 30, 2004.
“Antibiotic resistance and treatment of urologic infections “ Presented at Urology Rounds, Department of Urology, University of Manitoba, Winnipeg, Manitoba, May 5, 2004.
“Antibiotic resistance and treatment of neonatal infections: Focus on key pathogens “ Presented at Neonatology Rounds, University of Manitoba, Winnipeg, Manitoba, May 10, 2004.
“Ertapenem: A review of a new generation carbapenem “ Presented at an Infectious Diseases/Surgery Update, Winnipeg, Manitoba, June 3, 2004.
“Pharmacokinetics and pharmacodynamics of macrolides and ketolides “ Presented at an Infectious Diseases/Respirology Meeting, Montreal, Quebec, June 12, 2004.
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- differences between type 1 and 2 diabetes
- difference between diabetes 1 and 2
- difference between 2 1 and 3 1
- difference between 2 1 and 4 1
- difference between type 1 and 2 diabetes
- difference between angular 1 and 2
- difference between 2 1 and 5 1
- 7 1 arm vs 30 year fixed
- july 1 countdown
- 10 1 arm vs 30 year fixed
- geography paper 1 may june 2018
- 5 1 arm vs 30 year fixed